The role of serum IGM in immunity and autoimmunity. by Baker, N.D.V.
REFERENCE ONLY
UNIVERSITY OF LONDON THESIS
Degree Year Name of Author
AD 2 m
COPYRIGHT
This is a thesis accepted for a Higher Degree of the University of London. It is an 
unpublished typescript and the copyright is held by the author. All persons consulting 
the thesis must read and abide by the Copyright Declaration below.
COPYRIGHT DECLARATION
I recognise that the copyright of the above-described thesis rests with the author and 
that no quotation from it or information derived from it may be published without the 
prior written consent of the author.
Theses may not be lent to individuals, but the Senate House Library may lend a copy 
to approved libraries within the United Kingdom, for consultation solely on the 
premises of those libraries. Application should be made to: Inter-Library Loans, 
Senate House Library, Senate House, Malet Street, London WC1E 7HU.
REPRODUCTION
University of London theses may not be reproduced without explicit written 
permission from the Senate House Library. Enquiries should be addressed to the 
Theses Section of the Library. Regulations concerning reproduction vary according 
to the date of acceptance of the thesis and are listed below as guidelines.
A. Before 1962. Permission granted only upon the prior written consent of the 
author. (The Senate House Library will provide addresses where possible).
B. 1962 - 1974. In many cases the author has agreed to permit copying upon 
completion of a Copyright Declaration.
C. 1975 - 1988. Most theses may be copied upon completion of a Copyright 
Declaration.
D. 1989 onwards. Most theses may be copied.
This thesis comes within category D.
LOANS
This copy has been deposited in the Library of U  C U
This copy has been deposited in the Senate House Library, Senate House, 
Malet Street, London WC1E 7HU.

THE ROLE OF SERUM IgM IN 
IMMUNITY AND AUTOIMMUNITY
Nicole Duarte Vigar Baker
Thesis submitted to the University of London for the degree
of Doctor of Philosophy
Department of Medicine 
Centre for Rheumatology 
University College London
2005
UMI Number: U591945
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U591945
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
Summary
SUMMARY
Natural IgM has a wide range of actions in the immune system, is the 
first class of antibody to be produced, provides immediate defence against 
infection and assists subsequent development of the immune response. IgM 
is a potent complement activator, because of its pentameric structure and can 
have stable interactions with polymeric antigens. Here I investigated the 
effects of serum IgM deficiency on B cell development. Mice lacking serum 
IgM (Sp-) have an expansion in marginal zone (MZ) B cells with a 
corresponding reduction in follicular (FO) B cells. This expansion in MZ B 
cells is further accentuated in response to T-independent antigens. I have 
found that the increase in MZ/FO B cell ratio (and the expansion of peritoneal 
B1 cells) is fully reversed by administration of polyclonal, but not monoclonal, 
IgM. Natural IgM, by virtue of its polyreactivity, may enhance antigen driven 
signalling through the B cell receptor (BCR) and promote the formation of FO 
B cells. Conversely, in the absence of serum IgM, BCR signalling is reduced 
and MZ B cells are preferentially formed. In the absence of serum IgM, 
splenic follicular B cells have a shortened life span whereas peritoneal B1 B 
cells have a longer life span. However proliferation, and calcium mobilisation 
in response to BCR crosslinking in vitro is normal. These results demonstrate 
that natural IgM regulates the selection of B lymphocyte subsets in the 
periphery.
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Summary
It was previously shown that Sji- mice have an increased propensity 
for developing IgG autoantibodies. In order to determine whether serum IgM 
deficiency accelerates autoimmunity, Sp- mice were intercrossed into 
C57Black/6/pr mutant mice, which develop mild autoimmunity and 
lymphadenopathy. It was found that splenic marginal zone B cell numbers 
were further increased in the Ipr serum IgM deficient (S\i-lpr) mice. This 
increase in MZ B cells is associated with more severe lymphadenopathy, but 
not with worsening autoimmunity. Furthermore, the autoimmunity observed 
in these mice does not appear to be as a direct consequence of MZ B cell 
expansion.
3
Declaration
DECLARATION
I certify that this thesis does not incorporated any material previously 
submitted for a degree or diploma in any university, and that to the best of 
my knowledge and belief it does not contain any material previously 
published or written by another person except where due reference is made 
in the text.
4
Acknowledgements
ACKNOWLEDGEMENTS
I would like to thank my supervisor Michael Ehrenstein and David 
Isenberg for giving me the opportunity to do this work.
I would like to thank Maria, Sarah, Emma, Nathalie, Ian, Rachel, 
Luciene, Manu, Sonia, Sanjay and Karina for the support and friendship 
during these long 5 years.
Francis for all the help she has given me with the animals.
My family for believing that one day I was going to get there.
Robert and Noah for existing.
All my beloved friends.
Monica for looking after Noah.
5
NOAH FOR BRINGING LIGHT 
AND LAUGHTER TO MY LIFE
Table of contents
TABLE OF CONTENTS
Section 
TITLE PAGE
Page
1
SUMMARY
DECLARATION
ACKNOWLEDGEMENTS
TABLE OF CONTENTS
LIST OF FIGURES 11
LIST OF TABLES 13
LIST OF ABBREVIATIONS 14
INTRODUCTION 
Immunoglobulins 
B cell development 
B cell markers 
B cell sub-populations 
Transitional type 1 B cells 
Transitional type 2 B cells 
Follicular B cells 
Marginal zone B cells 
B1 B cells
Similarities between MZ and B 1 B cells
16
17
23
30
33
36
38
43
44 
46 
50
7
Table of contents
T independent response 
IgM deficient mice
The influence of genetic backgrounds in autoimmunity
HYPOTHESIS
AIMS
MATERIALS AND METHODS 
Mice
Breeding of S\i- mice 
Generation and breeding of V^ils mice 
Breeding of S i^- onto C57BL/6 Ipr mice 
Genotyping
Preparation of genomic DNA
PCR for genotyping S\i-, V^ils and Ipr mice
Injections and immunisation
Injection of polyclonal and monoclonal antibodies
Immunisation with PC-Ficoll
Immunoassays
ELISA for serum IgM
ELISA anti-phosphorylcholine (PC) Ficoll
ELISA anti dsDNA
ELISA anti-histones
ELISA anti- myeloperoxidase (MPO)
Cell isolation and cell culture 
Flow cytometric analyses 
Immunoflourescence staining of tissue sections
54
55
58
60
61
62
63
63
63
64
64
64
65
66
66
66
67
67
67
68
69
70
70
71
72
8
Table of contents
In vivo 5-bromo-2'-deoxyuridine (BrdU) incorporation 
Apoptosis measured by terminal dUTP nucleotide end labelling 
(TUNEL)
Measurement of intracellular calcium flux mobilization 
Statistical analyses
RESULTS 
B cell development
Marginal Zone B cells are expanded in serum IgM deficient (Sp-) 
mice
Transitional type 1 B cells are expanded in Sp- mice 
Polyclonal, but not monoclonal IgM or Vp1s transgene reverse the 
MZ B cell expansion
Polyclonal, but not monoclonal IgM or Vp1s transgene partially 
reverse the T1 B cell expansion
Polyclonal, but not monoclonal IgM or Vp1s reverses the peritoneal 
B1 B cell expansion 
Polyclonal IgM is polyreactive
Sp- follicular B cells have a higher rate of turnover than WT 
Sp- peritoneal B1 B cells have a lower rate of turnover than WT 
Splenic Sp- follicular B cells are dying more than the controls 
Sp- peritoneal B1 B cells are dying less 
Calcium mobilisation following IgM cross-linking shows no 
difference between WT and Sp- mice 
BCR engagement drives the differentiation of T2 B cells into a 
mature B cell phenotype
BCR engagement drives B cells to blast normally 
T independent response
MZ B cells are further expanded in Sp- mice in response to a T- 
independent antigen
T cell independent response to PC-Ficoll
72
73
74
74
75
76
76
79
79
86
86
88
88
90
93
93
96
99
101
103
103
103
9
Table of contents
Autoimmunity in Sp- Ipr mice
IgG anti-DNA antibodies in Ipr and S\x- Ipr mice 
Double Negative T cells in S\i-lpr and Ipr 
B cell subsets in S\i-lpr mice
Marginal zone and B1 B cells are further expanded S|x-lpr
107
107
109
109
114
DISCUSSION 118
CONCLUSIONS 128
FUTURE WORK 132
REFERENCES 133
APPENDIX 162
10
List of figures
LIST OF FIGURES 
Figure
INTRODUCTION
Figure 1. Transmembrane and secreted forms of immunoglobulins are 
derived from the same heavy-chain sequence by alternative RNA 
processing.
Figure 2. A pentameric IgM molecule
Figure 3. B cell development
Figure 4. Structure of the marginal zone
Figure 5. An overview of peripheral B-cell development
Figure 6. The follicular versus marginal zone B-lymphocyte cell-fate
decision
RESULTS
Figure 7. Splenic B cell subsets in Sp- mice 
Figure 8. Histology of Sp- mice spleens 
Figure 9. Transgene construct of Vp1s 
Figure 10. IgM serum concentration
Figure 11. Polyclonal, but not monoclonal IgM or Vp1s transgene 
reverse the MZ B cells expansion 
Figure 12. Histology of treated mice 
Figure 13. B1 peritoneal B cells
Figure 14. Reactivity of the three IgM preparations to PC, dsDNA,
myeloperoxidase (MPO), and histones
Figure 15. BrdU incorporation in splenic B cells
Figure 16. BrdU incorporation in peritoneal B cells
Figure 17. Apoptosis in splenic B cells
Figure 18. Apoptosis in peritoneal B cells
Figure 19. Calcium mobilisation following IgM cross-linking in splenic B
Page
20
22
26
29
35
42
77
78 
81 
82
84
85 
87 
89
91
92
94
95 
97
11
List of figures
cells
Figure 20. Calcium mobilisation following IgM cross-linking in peritoneal 
B cells
Figure 21. BCR engagement drives the differentiation of T2 B cells into
a mature B cell phenotype
Figure 22. Blasting B cells upon BCR stimulation
Figure 23. Splenic B cell subsets in immunized S\i- mice
Figure 24. T independent response to PC-Ficoll
Figure 25. IgG anti-dsDNA antibodies
Figure 26. Splenic double negative T cells, B and T cells
Figure 27. Lymph node double negative T cells, B and T cells
Figure 28. B cell subsets in 4 month old mice
Figure 29. B cell subsets in 12 month old mice
Figure 30. Marginal zone B cells in Ipr and Sjx- Ipr mice
Figure 31. Transitional type 1 B cells in Ipr and S\i- Ipr mice
Figure 32. Peritoneal B 1 B cells in Ipr and S\x- Ipr mice
98
100
102
105
106 
108 
110 
111 
112 
113
115
116 
117
12
List of Tables
LIST OF TABLES
Table Page
INTRODUCTION
Table 1. The properties of the human immunoglobulin isotypes 
Table 2. Murine CD antigens
Table 3. B cell developmental stages in the bone marrow 
Table 4. Comparison of phenotype and function of B cell subsets 
Table 5. Mutations in molecules that affect B cell development
19
32
33
52
53
RESULTS
Table 6. Percentage of subpopulations of B cells in the spleen 
Table 7. Immunised mice with PC-Ficoll. Percentage of subpopulations 
of B cells in the spleen
80
104
13
List of abbreviations
LIST OF ABBREVIATIONS
APC- antigen presenting cell
Baff- B cell activating factor of the TNF family
BCR- B cell antigen receptor
BrdU- 5-bromo-2'-deoxyuridine
BSA- Bovine serum albumin
C- Constant
CD- Cluster of differentiation 
D- Diversity
dsDNA- double stranded DNA
ELISA- Enzyme linked immunosorbent assay
FACS- Fluorescence activated cell sorter
FCS- Fetal calf serum
FDC- Follicular dendritic cells
FITC- Fluorescence isothyiocyanate
FO- Follicular
H- Heavy
HEL- Hen egg lysozyme 
HRP- Horse radish peroxidase 
HSA- Heat stable antigen 
Ig- Immunoglobulin 
IL7R- Interleukin 7 receptor
14
List of abbreviations
ITAM- Immunoregulatory tyrosine activation motifs 
J- Joining 
L- Light
LPS- Lipopolysaccharide
MHC- Major histocompatibility complex
MZ- Marginal zone
NP- 4-hydroxy-3-nitrophenylacetyl
PALS- Periarteriolar lymphocyte sheath
PBS- Phosphate buffered saline
PC- Phosphorylcholine
PCR- Polymerase chain reaction
PE- Phycoerytherin
T1- Transitional type 1
T2- Transitional type 2
TG- Transgenic
Tl- Thymus independent
TLR- Toll like receptor
TUNEL- Terminal dUTP nucleotide end labeling 
V- Variable
15
Introduction
INTRODUCTION
16
Introduction
INTRODUCTION 
Immunoglobulins
Each B cell is genetically programmed to encode a surface receptor 
specific for a particular antigen. The surface immunoglobulin (Ig) is the B 
cell antigen receptor (BCR), which has two main roles, firstly to transmit 
signals that regulate B cell fate decisions and secondly to mediate antigen 
processing, leading to presentation of antigen to T cells, which allows full 
activation of B cells in the effector phase.
The BCR is composed of the ligand recognising Ig heavy and light 
chains in a noncovalent association with Iga and Igp transmembrane 
proteins. Iga and Igp are associated as disulfide-linked heterodimers and 
mediate the signal transduction function of the BCR. Antigen mediated 
aggregation of BCR complexes is required to trigger and sustain the 
signaling processes necessary for generating a signal of sufficient strength 
and duration to elicit responses by immature or mature B cells. Aggregation 
triggers an intracellular signaling cascade that requires immunoregulatory 
tyrosine activation motifs (ITAMs) present on the cytoplasmatic domains of 
Iga and Igp (Wienands, 2000).
Immunoglobulins are remarkable not only for the diversity of their 
antigen-binding sites, but also for their versatility as effector molecules. 
Immunoglobulins consist of two heavy (H) chains (each with four domains)
17
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and two light (L) chains ( k  or X, each with two domains). The specificity of 
an antibody response is determined by the antigen-binding site, which 
consists of the two variable (V) domains, VH and VL. The effector action of 
the antibody is determined by the isotype of its heavy-chain constant (C) 
region. The heavy-chain variable (V) domain can become associated with 
the C region of any isotype through the process of isotype switching, which 
involves VD (diversity) J (joining) recombination. The five isotypes of 
immunoglobulin are IgM, IgD, IgG, IgE, and IgA. In the mouse, IgG 
antibodies can be further subdivided into four subclasses (lgG1, lgG2a, 
lgG2b and lgG3). The functions and properties of the different subclasses of 
human immunoglobulins are summarised on Table 1, and Figure 1 shows 
the transmembrane and the secreted from of immunoglobulins (Janeway et 
al, 2001).
18
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Table 1. The properties of the human immunoglobulin isotypes. IgM is
so called because of its size: although monomeric IgM is only 190 kDa, it 
normally forms pentamers, known as macroglobulin (hence the M), of very 
large molecular weight. IgA dimerises to give a molecular weight of around 
390 kDa in secretions. IgE antibody is associated with immediate-type 
hypersensitivity. When fixed to tissue mast cells, IgE has a much longer 
half-life than its plasma half-life shown here (Janeway et al, 2001).
Immunoglobulin
IgGi lgG2 lgG3 lgG4 IgM Ig A1 lgA2 Ig D IgE
Heavy chan Tt r 2 r 3 P « 2 €
Mclecjar wagnt skDa; 146 146 165 146 970 160 160 184 188
Serum level 
{mean acUl mg ml"1)
9 3 1 05 1.5 30 05 003 5X10"4
Half- le tn serum (days; 21 20 7 21 10 6 6 3 2
Classics pathway of 
corrDener*. activafior 1 * * + | | - P [ - - — -
Attemaive pathway cf 
compwmer: acnvaiior - — | - | + - - | -
Placental transfer +
| 
t +  | I - - - " I —
andng lo nac'ophages 
and other phagocytes 1 + - -4- I * I - +  | | + — +
High-affinity birxsmg to 
mast cois and basoon s - I ” - R
Heactivty witn 
staphylococcal Protan A l + I + | ♦ | + I - -
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Figure 1. Transmembrane and secreted forms of immunoglobulins are 
derived from the same heavy-chain sequence by alternative RNA 
processing. Each heavy-chain C gene has two exons (membrane-coding 
(MC) yellow) that encode the transmembrane region and cytoplasmic tail of 
the transmembrane form, and a secretion-coding (SC) sequence (orange) 
that encodes the carboxy terminus of the secreted form. In the case of IgD, 
the SC sequence is present on a separate exon, but for the other isotypes, 
including IgM as shown here, the SC sequence is contiguous with the last C- 
domain exon. The events that dictate whether a heavy-chain RNA will result 
in a secreted or transmembrane immunoglobulin occur during processing of 
the initial transcript. Each heavy-chain C gene has two potential 
polyadenylation sites (shown as pAs and pAm). In the upper panel, the 
transcript is cleaved and polyadenylated (AAA) at the second site (pAm). 
Splicing between a site located between the Cp4 exon and the SC 
sequence, and a second site at the 5’ end of the MC exons, results in 
removal of the SC sequence and joining of the MC exons to the C i^4 exon. 
This generates the transmembrane form of the heavy chain. In the lower 
panel, the primary transcript is cleaved and polyadenylated at the first site 
(pAs), eliminating the MC exons and giving rise to the secreted form of the 
heavy chain (Janeway et al, 2001).
21
Introduction
The IgM molecule is a pentamer of 4-chain structure. Each heavy 
chain has a molecular weight of approximately 65000 and the whole 
molecule has a molecular weight of 970000. The p. chains of IgM have an 
extra constant region domain. The sub-units of the pentamer are linked by 
disulphide bonds between the Cp3 domains, and possibly by disulphide 
bonds between the C terminal 18 residue peptide tailpiece. The complete 
molecule consists of a densely packed central region with radiating arms 
(Figure 2). The dislocation resulting in the “crab like” configuration appears 
to be related to the activation of complement by IgM (Turner et al, 1998).
Figure 2. A pentameric IgM molecule. The five subunits are held together 
by disulfide bonds. A single J chain, which has a structure similar to that of a 
single Ig domain, is disulfide-bonded between two p heavy chains. The J 
chain is required for the polymerization process. The addition of each 
successive four-chain IgM subunit requires a J chain, which is then 
discarded, except for the last one, which is retained. (Alberts et al, 1994).
22
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B cell development
In the mouse B cells are generated from pluripotent hematopoietic 
stem cells in the liver during mid to late fetal development and in the bone 
marrow after birth. In addition to being a site for B cell development, the 
postnatal bone marrow contains mature T cells and plasma cells.
After commitment to B cell lineage in the bone marrow, developing 
murine B cells require signals through both their B cell antigen receptor 
(BCR) and interleukin 7 receptor (IL7R) to allow differentiation and survival. 
BCR generation by VDJ recombination of immunoglobulin heavy and light 
chains initiates in pro-B cell, where heavy DJ joins are initially made, 
followed by VDJ joins. Successful recombination allows feedback and 
expansion of pro-B cells by the pre-BCR to enter the pre-B stage of 
development. At this stage, light chain VJ joins are made and allelic 
exclusion terminates VDJ recombination (Bassing et al, 2002). B cells that 
fail to properly undergo VDJ rearrangement to generate a functional BCR 
undergo developmental arrest and apoptosis (Nemazee et al, 2000).
During B cell development, immature B cells developing in the bone 
marrow are the first cells to express the prototypic form of the BCR, 
consequently the immature B cell is the first representative of the B cell to 
recognise and respond to antigen in a clonotypically restricted manner, thus 
the immature B cell is of critical importance to the immune system, for it is at 
this stage that antigen specific positive and negative selection events initially
23
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operate. Such selective events exert a profound influence on the generation 
of the peripheral mature B cell repertoire (King et al, 2000).
An adult mouse produce about 2x107 of immature B cells per day 
(Osmond, 1991) and only around 10%-20% of the immature B cells made in 
the bone marrow migrate to the spleen (Allman et al, 2001, Rolink et al, 
1998). The loss of the initial immature B cells may be due to several types 
of negative selection (receptor editing, clonal deletion and anergy) to avoid
autoreactivity. Most of the work done on negative selection of B cells in the
bone marrow has been done on transgenic models, the one mostly used is
the HEL (hen egg lysozyme) system, where B cells express transgenic
immunoglobulin receptors for HEL (MD4 anti-HEL Ig [IgHEL]) (Hartley et al, 
1991, Goodnow et al, 1989, Goodnow et al, 1988 and Cooke et al, 1994).
Receptor editing operates at genetic level, replacing expressed 
defective and/or self-reactive variable (V) genes with upstream V genes 
coding for hopefully harmless receptors (Gay et al, 1993; Radic et al, 1993 
and Tiegs et al, 1993). The re-arrangement of heavy (H) and/or light (L) 
chain genes are induced by encounters with auto-antigens to change 
specificity from self to non self.
Another form of negative selection is by clonal deletion by apoptosis 
of self-reactive immature B cells that are capable of crosslinking 
immunoglubulin receptors on B cells (BCR) with high avidity in the bone 
marrow (Hartley et al, 1991, Nemazee et al, 1989, Okamoto et al, 1992 and 
Sandel et al, 1999). Self-reactive B cells expressing transgenic Ig receptors
24
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for HEL undergo deletion or receptor editing in the bone marrow when they 
encounter systemic membrane-bound HEL (mHEL) expressed on the cell 
surface under the class I promoter (Hartley et al, 1991).
Immature self-reactive B cells can also become functionally 
inactivated (anergic), but are not physically eliminated. IgHEL B cells that 
encounter abundant but lower avidity soluble HEL (sHEL) at a level in 
excess of 10-20 ng/ml enter the repertoire but are held in a potentially 
reversible state of functional inactivation (Goodnow et al, 1989, Goodnow et 
al, 1988 and Cooke et al, 1994) and have a shortened life span which is 
largely due to their inability to compete with other B cells (Cyster et al, 1994 
and Cyster et al, 1995). Autoreactive B cells that escape tolerisation in the 
bone marrow are eliminated on peripheral encounter with autoantigen (Loder 
et al, 1999 and Russell et al, 1991), whereas B cells that bind low avidity or 
rare antigens may remain functionally ignorant (Aldelstein et al, 1991 and 
Hannum et al, 1996). When B cells emerge from bone marrow into the 
periphery, they are still functionally immature, expressing high levels of 
surface IgM but little surface IgD (Janeway et al, 2001). Figure 3 briefly 
illustrates negative selection in the bone marrow.
25
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Figure 3. B cell development Receptor editing is activated throughout B
lymphopoiesis. Selection checkpoints mediated by the pre-BCR or the BCR 
are specified. B cells that fail to fulfil appropriate receptor requirements 
stimulate receptor editing and undergo secondary recombination (Edry et al, 
2004).
B cell development also depends on BCR expression and appropriate 
signaling, a process referred to as positive selection. Positive selection in 
the bone marrow takes place at the immature stage during the process of 
entry into the more stable peripheral B cell pool. This selection happens by 
antigens/autoantigens binding to the heavy chain V region independently of 
the light chain (Gu et al, 1991) to enrich the repertoire for functional diversity. 
Mice in which the BCR signaling is impaired by the deletion of syk tyrosine 
kinase (Turner et al, 1997) or by the truncation of Iga (Torres et al, 1996) 
show a marked reduction in the transition from immature B cells from the 
bone marrow to the spleen.
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The generation of lymphocytes in primary lymphoid organs is followed 
by their migration into peripheral secondary tissues; spleen (blood borne 
antigens) through the terminal branches of central arteorioles, thus arriving 
in the marginal zone blood sinusoids (MacLennan and Chan, 1993) from 
which they penetrate into the outer zone of the periarteriolar lymphocyte 
sheath (PALS), where they become part of the B cell rich follicular areas 
(MacLennan and Gray, 1986); lymph nodes (antigens from the interstitial 
tissue fluid and lymph) or lymphoid tissue (MALT- Mucosa Associated 
Lymphoid Tissue) (Lydyard and Grossi, 1998).
The spleen is divided into two parts, the white pulp and the red pulp. 
The white pulp consists of lymphoid tissue, arranged around a central 
arteriole to form the periarteriolar lymphoid sheaths (PALS). PALS are 
composed of T and B cell areas. B cells are organised into either primary 
(unstimulated) follicles, which aggregate naive B cells, or secondary 
(stimulated) follicles. Secondary follicles possess a germinal centre, an area 
in which B cells involved in the immune response are proliferating and 
undergoing somatic hypermutation and also contain memory B cells. T cell 
zones and follicles are surrounded by marginal zones, containing a unique 
population of B cells, the marginal zone B cells (MZ), which do not re­
circulate. The marginal zone is adjacent to the red pulp and separated from 
the follicles by a loose endothelial structure, the marginal sinus, as seen in 
figure 4 (Lortan et al, 1987).
27
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The marginal zone also contains dendritic cells as well as two 
different types of macrophages, one of which lines the marginal sinus (the 
so-called ‘metallophilic macrophages’) whereas the other is scattered 
throughout the marginal zone. The B cell zone contains a network of 
follicular dendritic cells (FDCs), which are mainly concentrated in the area of 
the follicle most distant from the central arteriole (Figure 4). Follicular 
dendritic cells differ from the dendritic cells, as they are not leukocytes and 
are not derived from bone marrow precursors. They are not phagocytic and 
do not express MHC class II proteins. Follicular dendritic cells seem to be 
specialised to capture antigen in the form of immune complexes. The 
immune complexes are not internalised; they remain intact on the follicular 
dendritic cell surface, where the antigen can be recognised by B cells. 
Follicular dendritic cells are also important in the development of B cell 
follicles (Janeway et al, 2001).
Lymph nodes consist of a B cell area (cortex) and T cell area 
(paracortex), and a central medulla, formed by cellular cords containing 
macrophages, T, B and lymphocytes and plasma cells (Lydyard and Grossi,
1998).
28
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MZ Macrophage
MZ B Cell
Mantle T Cell
B Cel1 Central
Arteriole
Marginal
ZoneMarginalSinus
Terminal Metallophilic 
Arteriole Macrophage
Follicle
Figure 4. Structure of the marginal zone. Blood from the central 
circulation moves from the central to terminal arterioles before emptying into 
the marginal sinus from which it percolates into the red pulp (arrows). 
Particulate and soluble antigens acquired by macrophages and dendritic 
cells are presented to small number of MZ T cells (not shown) and MZ B 
cells eliciting rapid responses (Morse et al, 2001).
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B cell markers
The molecule CD19 characterises most of B lineage stages, because 
is expressed from early pre-B cells at the time of heavy chain rearrangement 
until plasma cell differentiation (Li et al, 1996). CD19 associated with the 
complement receptor for C3d (CD21) plays an important part in antigen- 
induced B cell activation via the antigen binding antibody receptor. 
Antibodies already bound to antigens can activate the complement system. 
When the antigen is coated with C3d, it produces a more potent antigen, 
which in turn leads to more efficient B-cell activation and antibody production 
(Janeway et al, 2001).
B220, a high molecular mass (220kDa) isoform of CD45 is the main 
marker used to identify murine B cells, although there are several non B 
lineage cell types in the mouse bone marrow that also express this molecule 
(Rolink et al, 1996).
Immature and mature B cells can be identified by the intensity of cell 
surface heat-stable antigen (HSA), also known as CD24, immature B cells 
expressing high levels and mature B cells low levels of HSA (Allman et al, 
1992 and Allman et al, 1993).
Follicular and T2 B cell express high levels of the low affinity Fee 
receptor (FceRII) CD23, a C-type lectin (Janeway et al, 2001).
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Marginal Zone B cells express high levels of the MHC class l-like 
molecule CD1d, which has a specialized role in presentation of lipid 
antigens.
Complement receptors for C3b (CR1, CD35) and C3d (CR2, CD21) 
are commonly found on T2, FO and MZ B cells and are associated with 
activation and possibly, homing of the cells (Li et al, 1996).
B1 cells (foetal B cell development) expresses CD5+ and B2 or 
conventional B cells (generated in adult bone marrow) do not express CD5. 
B1 phenotype B cells are further subdivided into B1a (CD5 +ve) and B1b 
(CD5 -ve) (Hardy et al, 2001).
Table 2 shows most of the molecules that are expressed on the 
surface of B cells.
31
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Table 2. Murine CD antigens
CD antigens Cellular
expression
Functions Other names Family
relationships
CD1d T cells, B cells, 
dendritic and NK 
cells
Antigen 
presentation. 
Glycoprotein with 
structural homology 
to MHC class I
CD1.1, Ly-38 Immunoglobulin
CD5 T and a subset of 
B cells (B1a B 
cells).
Ligand of CD72 T1, Ly 1 Scavenger
receptor
CD19 B cells Forms complex with 
CD21 (CR2) and 
CD81 (TAPA-1); co­
receptor for B cells. 
Cytoplasmic domain 
binds cytoplasmic 
tyrosine kinases and 
PI 3-kinase
Immunoglobulin
CD21/CD35 Mature B cells, 
follicular dendritic 
cells and 
macrophages
Receptor for 
complement 
component C3d, 
Epstein-Barr virus.
With CD19 and 
CD81, CD21 forms 
co-receptor for B 
cells
CR2 and CR1 Complement 
control protein 
(CCP)
CD22 Mature B cells 
and plasma cells
Negative regulation 
of B cell activation
Lyb-8.2 Immunoglobulin
CD23 Mature B cells, 
activated 
macrophages, 
eosinophils and 
follicular dendritic 
cells
Low-affinity receptor 
for IgE, regulates IgE 
synthesis; ligand for 
CD19:CD21: CD81 
co-receptor
IgE Fc receptor C-type lectin
CD24 B cells and 
granulocytes
Ligand of CD62P (P- 
selectin)
Heat stable 
antigen
Membrane protein
CD40 B, monocytes 
/macrophage 
and follicular 
dendritic cells
Binds to CD154 
(CD40L), co­
stimulatory molecule
TNF receptor
CD45/B220 B cells, abnormal 
T cells and NK 
cells
Tyrosine 
phosphatase, 
augments signaling 
through antigen 
receptor of B and T 
cells
Leukocyte 
common antigen 
(LCA), Ly-5 or 
T200 and B220
Transmembrane 
Protein Tyrosine 
Phosphatase
Pharmingen Catalog 2002 and Janeway et al, 2001)
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B cell sub-populations
B cells can be subdivided in the bone marrow using different cell 
markers and looking at their immunoglobulin gene rearrangement status 
(Osmond et al, 1990).
Table 3. B cell developmental stages in the bone marrow
Developmental stage Hardy’s nomenclature Cell markers
Early pro B Hardy’s Fraction A AA4.1 B220IOW CD43 
CD24low
Intermediate pro B Hardy’s Fraction B CD19AA4.1 B220IOW 
CD43 CD24|0W
Late pro B Hardy’s Fraction C AA4.1 B220IOWCD43 
CD24|0W CD19
Large pre B Hardy’s Fraction C’ AA4.1 B220|OW CD43 
CD24hi9h CD19 lgMhi911
Small pre B Hardy’s Fraction D AA4.1 B220 CD24ni9n 
CD19 lgMhlgh
Immature Hardy’s Fraction E AA4.1 B220 CD43 
CD24high CD19 lgMhigh 
lgDlow
(Hardy et al, 2001 and Cancro et al, 2004).
B cells in the periphery have also been divided into sub-populations 
depending on their cell surface markers and phenotype. After migrating 
from the bone marrow to the spleen, immature B cells pass through two
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transitional stages. They are known as transitional B cells type I (T1 or 
newly formed cells-NF), transitional B cells type 2 (T2), before differentiating 
into naive mature B cells.
Marginal Zone (MZ) B cells can be generated from T2 or maybe from 
mature B cells.
Mature or follicular (FO) B cells can be generated from T1 or T2 B 
cells (Figure 5).
B cells can be distinguished using molecular makers;
T1: B220low CD19 lgMhighlgDlowCD21low CD23neg CD24high 
T2: B220low CD19 lgMhighlgDhighCD21high CD23pos CD24high 
FO: B220high CD19 lgMlow |gDhigh CD21intermediale CD23high CD24|0W 
MZ: B220 CD19 lgMhigh lgDl0W CD21high CD23negCD24high 
B1: B220 CD19 lgMhigh lgDl0W CD23negCD24 CD5 
(Allman et al, 2001, Loder et al, 1999, Samardzic et al, 2002, Li et al, 
2001 and Su et al, 2002a)
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REARRANGEMENT REARRANGEMENT REARRANGEMENT
Figure 5. An overview of peripheral B-cell development. B-cell 
progenitors sequentially rearrange their Ig heavy- and light-chain genes in 
the bone marrow and, subsequently, (a) immature B cells emigrate to the 
spleen where they can be initially identified as newly formed (NF) B cells, (b) 
Newly formed B cells enter the follicle where they may be initially found 
either as lgMhilgDh'CD21'nt precursors (FII-FP) of mature follicular B cells or 
lgMhilgDhiCD21hl precursors (FII-MZP) of MZ B cells. It is unclear whether 
FII-MZP cells are derived from FII-FP cells. MZ B cells (lgMhllgD- 
CD21h,CD1dhl; MZ) are long-lived B cells whereas mature follicular B cells 
(lgDhllgMl0; FI) have lifespan of a few months. B1 B cells are not included in
this scheme (Cariappa and Pillai, 2002).
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Transitional type 1 B cells
BCR signaling in immature B lymphocytes in the spleen is required for 
their maturation into long lived mature B cell pool. Immature B cells are 
short-lived (3-4 days), indicating that the vast majority of these cells either 
differentiate into mature B cells or die (Allman et al, 1993, Allman et al, 1992 
and Rolink et al, 1998). These immature B cells can be divided into two 
distinct subsets: transitional 1 (T1) and transitional 2 (T2) B cells (Carsetti et 
al, 1995, Loder et al, 1999). In vivo experiments indicate that T1 give rise to 
T2. T1 B cells do not actively proliferate in response to B cell growth factor 
(Baff) (Batten et al, 2000).
T1 B cells are characterised by B220low CD19 lgMhi9h lgDl0W CD21low 
CD23neg CD24hi9h and are essentially all in the G0-G1 phase of the cell 
cycle, do not proliferate or up regulate cyclin D2, which is a critical cell cycle 
regulator in response to antigen receptor activation. BCR stimulation does 
not rescue T1 cells from death, and instead enhance apoptosis. This may 
be due to the lack of induction of anti-apoptotic factors such as A1/BFL-1 
and the proto-oncogene Akt/PKB, which is important for a range of cellular 
growth and survival signals. The T1 subpopulation is thought to be a target 
for BCR induced negative selection in the periphery and act as a distinct 
checkpoint for selection into the mature B cell pool whereby T1 B cells with 
receptor specificities for blood-borne self antigens are deleted by negative 
selection (Su et al, 2002a).
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T1 B cells are located in the bone marrow, blood and spleen at the 
outer periarteriolar lymphoid sheat (PALS) outside of the follicle (Loder et al, 
1999). T1 cells migrating to the spleen expressing antigens receptors with a 
high affinity to soluble antigens in the blood are likely to die via antigen 
induced apoptosis. Upon entry into the spleen, T1 cells remain in the PALS, 
where additional blood borne self-antigens trapped by the spleen may 
further drive negative selection. The remaining T1 cells enter the primary 
follicle and become T2 cells (Su et al, 2004).
Mice lacking the cytoplasm domain of Iga (Mb1;CD79a) do not have 
T1 cells, suggesting that T1 cells require a low threshold tonic BCR signal to 
generate the T2 subset (Torres et al, 1996 and Loder et al, 1999).
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Transitional type 2 B cells
Transitional type 2 B cells are situated within primary follicles adjacent 
to mature B cells (Loder et al, 1999), and are likely to encounter a unique set 
of antigens, possibly on follicular dendritic cells (Su et al, 2004). They can 
process and present antigens as peptide:MHC class II complexes, however 
their ability to activate T cells and elicit help signals is compromised 
compared to follicular B cells (Chung et al, 2003). Most T2 are in G2/M 
phase of cell cycle, indicating that this subset of immature B cell is more 
activated than the T1 B cell subset and can develop into phenotypically 
mature follicular B cells after 1-2 days in vivo (Carsetti et al, 1995) and in 
vitro (Petro et al, 2002). T2 cells also actively proliferate in response to Baff 
(Batten et al, 2000).
T2 B cells characterised by CD21high CD24high generate proliferative, 
antiapoptotic and differentiation signals in response to BCR engagement, 
indicating that BCR signaling is very likely playing a critical role in T2 B cell 
survival and maturation, and these cells are a target for antigen driven 
positive selection (Su et al, 2002). Hardy’s group do not show that T2 cells 
proliferate upon BCR engagement, this difference may be because they 
characterised their T2 subpopulation using alternative cell markers, namely 
lgMhlgh CD23pps AA4pos (Allman et al, 2001).
Recent evidence has suggested that B cell development is dependent 
on endogenous antigens and that only a minority of immature B cells are 
selected for maturation (Allman et al, 1993, Hardy and Hayakawa, 2001 and
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Cariappa and Pillai, 2002). Once the immature B cell has reached the 
spleen it can develop into follicular (FO) or marginal zone (MZ) B cells and 
this decision is thought to be governed by the strength of B cell receptor 
(BCR) signaling (Cariappa et al, 2001). Cells that receive a weak signal via 
the BCR differentiate into marginal zone B cells and cells that receive strong 
signals via the BCR are likely to become follicular B cells (Pillai et al, 2004).
Targeted deletions of BCR signaling components, including Bruton’s 
tyrosine kinase (Btk), phospholipase Cy2 (PLCy2), or protein kinase p 
(PKCp). Each deletion leads to a loss of BCR dependent nuclear factor-icB 
(NFkB) activation, a crucial pathway for mediating cell survival, suggesting 
that one key response initiated by BCR engagement in T2 cells is NFkB 
dependent survival signaling (Su et al, 2002, Petro et al, 2000, Bajpai et al, 
2000, Saijo et al, 2002, Wang et al, 2000 and Leitges et al, 1996). 
Disruption of downstream BCR signaling components, including Btk, C-cell 
linker protein (BLNK), phosphoinositide 3-kinase (PI3K), PLCy2, or VAV 
result in developmental arrest at the T2 to mature B cell development (Su et 
al, 2002, Pappu et al, 1999, Xu et al, 2000, Suzuki et al, 1999, Fruman et al, 
1999, Wang et al, 2000 and Martin and Kearney 2000).
Su et al, have proposed a model for a dual signaling pathway 
controlling peripheral B cell survival and differentiation. This model 
delineates two major BCR dependent signals: (I) a Btk-PKCp-NFicB pathway 
required for the survival and maintenance of splenic B cells and (II) a Btk
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dependant/PKCp independent maturation signal driving the differentiation of 
T2 cells into the follicular mature B cell pool (Su et al, 2004).
Emerging in vivo data suggests that BCR and TLR activation are 
required for the generation of adaptive (FO) versus innate (MZ) mature B 
cells, respectively. In the presence of BCR engagement T2 cells are 
positively selected to become follicular B cell and if TLR specific bacterial 
ligands are also present, the generation of FO B cells are greatly enhanced. 
In the absence of strong BCR signals, T2 B cells have two fates: (I) In the 
presence of microbial products and TLR activation, T2 B cells differentiate 
into MZ B cells. (II) In the absence of both BCR and TLR stimulation, T2 B 
cells are likely to undergo cell death by neglect (Wei et al, 2004).
Baff (BLyS, TALL-1, THANK, z-TNF-4 and TNFSF20) B cell activating 
factor of the TNF family, plays a dominant lineage specific role in the 
selection and homeostatic control of the peripheral B cell pool, enhancing B 
cell survival. Baff is generated by monocytes, macrophages, neutrophils 
and dendritic cells and can be induced by a variety of inflammatory 
cytokines. Baff interacts with three receptors (BCMA, TACI, 
BR3/Bcmd/BAFF-R) found on B cells. Baff is thought to control the 
maturation of B cells, specially the development from immature to mature B 
cells. Baff deficient mice have normal numbers of T1 B cells, indicating that 
T1 cells do not depend on Baff for survival, but T2 and mature B cells in the 
periphery need Baff for survival (Schiemann et al, 2001). Baff-R deficient 
mice have a very similar phenotype to Baff deficient mice indicating that this
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receptor is a dominant mediator of quiescent peripheral B cell survival 
(Thompson et al, 2001). Overexpression of Baff causes B cell hyperplasia, 
hyperglobulinaemia, splenomegaly, adenopathy, production of 
autoantibodies, glomerolonephritis, and expanded T2 and MZ B cells (Gross 
et al, 2000, Mackay et al, 1999 and Khare et al, 2000). Baff dictates the 
lifespan of B cells, thereby mediating homeostatic control of the peripheral B 
cell pool.
Recently, Pillai (Figure 6) suggested that there are two distinct types 
of transitional B cells and these cells can develop into follicular or marginal 
zone B cells. A specific “transitional follicular B cell precursor” (T2-FP), 
expressing lgMhi9h lgDhiQh CD21in,errnediate CD1dl0W, these cells can be 
distinguished functionally from “transitional marginal zone B cell precursor” 
(T2-MZP), expressing lgMhigh lgDhi9h CD21hi9h CD1dhi9h (Pillai et al, 2004). 
T2-MZP B cells are lost in mutant mice which do not make marginal zone B 
cells such as Aiolos and Notch-2, indicating that these cells are probably the 
MZ precursors (Cariappa et al, 2001 and Saito et al, 2003).
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Figure 6. The follicular versus marginal zone B-lymphocyte cel I-fate 
decision. Relatively strong (B-cell receptor) BCR signals drive FO B-cell 
differentiation, whereas weaker BCR signals are permissive for the 
development of MZ B cells via an intermediate MZP cell. MZ B-cell 
development is facilitated by Notch-2 and requires NF-Bp50. NF, newly 
formed B cell (equivalent to T1 cells); FP, follicular precursor B cells (a 
subset of B cells sometimes categorized as T2 cells); MZP, marginal zone 
precursor B cells (also called T2 cells); FO, follicular B cells; and MZ, MZ B 
cells (Pillai et al, 2004).
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Follicular B cells
Developing B cells that receive relatively strong signals via the BCR 
(i.e. cells that recognise self-antigens with moderately high avidity) can 
readily commit to a mature follicular B cell fate (Pillai et al, 2004). Mature B 
cells are relatively long lived with a half-life of around 2-3 months (Hao and 
Rajewsky, 2001) and can be characterized by B220high CD19 lgMl0W lgDhl9h 
CD21intermediate CD23high CD24l0W
Follicular B cells reside primarily in the follicles of the splenic white 
pulp and recirculate to the lymph nodes and bone marrow. They are 
referred to as naive, mature conventional B cells, they respond to antigen 
stimulation, and in the presence of costimulation by helper T cells participate 
in germinal center reaction. Within the germinal center activated follicular B 
cells proliferate and undergo somatic hypermutation, affinity maturation and 
isotype switching. These activated follicular B cells serve as antigen 
presenting cells, promoting T cell activation and further differentiate into 
highly specialized effector cells including plasma and memory B cells. Thus, 
the key B cell lineage outcome of germinal center reaction is an adaptive 
immune response characterised by the generation of high affinity, isotype 
switched, antigen specific antibodies (McLenann et al, 1997).
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Marginal zone B cells
Marginal zone (MZ) B cells represent a distinct population of 
apparently “naive” B cells with partially activated phenotype. They are 
sparse at birth, and mainly derived from hematopoietic stem cells of fetal 
liver origin. These cells are self-renewing and extremely long-lived, 
apparently surviving as long as the host (Hao and Rajewsky, 2001). In the 
spleen, they are exclusively located in the periphery of the periarteriolar 
lymphoid sheath (PALS), at the border of white and red pulp (Oliver et al, 
1999 and Dammers et al, 1999).
MZ B cells are among the first population of cells to “see” blood-borne 
antigens and play an important role in host defence against bacterial 
pathogens (Martin et al, 2001a). These responses are primarily directed 
against T-independent multivalent antigens, however recently it was shown 
that MZ B cells can participate in T-dependent responses as well. Activated 
MZ B cells are potent protein antigens presenters to CD4 T cells and have 
the ability to induce antigen specific T cell clonal expansion and production 
of cytokines (Attanavanich et al, 2004).
They can be distinguished from other B cells by cell membrane 
markers. MZ B cells are B220 CD19 lgMhi8h lgDlow CD21hi9h CD23ne9 
CD24high and exhibit high levels of B7.1 and B7.2 indicative of previous 
antigenic experience (Oliver et al, 1999).
Mice that lack CD19, which enhances B cell signaling, have a 
selective reduction of MZ B cells (Martin and Kearney, 2000). Conversely,
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mice that lack aiolos, a zinc finger transcription factor of the ikaros family 
expressed in B cells, which inhibits BCR signaling, have a reduced MZ 
(Cariappa et al, 2001). MZ B cells are also decreased in Lyn (cytoplasmic 
protein tyrosine kinase) deficient mice (Seo et al, 2001) and in mice in which 
the ITAM (immunoreceptor tyrosine-based activation motif) of Iga has been 
mutated (Kraus et al, 2001). Both Lyn and Iga are known to negatively 
regulate the BCR. Thus, MZ B cells are preferentially formed over follicular 
cells when there is a reduced signaling through the BCR.
Although BCR signaling plays a very important role in the 
differentiation of marginal zone B cell, other factors may influence it too, 
such as Notch. Notch 2 deficient B cells fail to generate MZ B cells. In 
mammals, the Notch family encodes four transmembrane receptor proteins 
(Notch 1-4) that influence cell fate decision by regulating transcription 
(Allman et al, 2002)
Notch-2, nuclear factor-KB, and other genes are essential for marginal 
zone B cell development, instructive signals delivered by the antigen 
receptor represent the primary force driving positive selection and lineage 
commitment in B lymphocytes (Pillai et al, 2004).
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B1 B cells
B1 cells were first described based on the phenotype; B1 cells (fetal B 
cell development) expressing CD5+ and B2 or conventional B cells 
(generated in adult bone marrow) not expressing CD5. B1 phenotype B 
cells are further sub-divided into B1a (CD5+) and B1b (CD5-) (Hardy et al, 
2001). Recent data reveal differences between B1 compared with B2 B cells 
development in terms of initial repertoire establishment and cellular 
selection. It appears that CD5 induction may be a consequence of positive 
selection in B1 development resulting in enrichment of auto-reactive B cells 
in this population (Hayakawa and Hardy, 2000). There is some suggestion 
that it is possible to generate auto-reactive “B1 like” CD5- cells during B2 
development, possibly by deregulation of normal tolerance mechanisms 
(Cong et al, 1991).
B1 cells are the predominant B cell type in the peritoneal cavity, are 
infrequent in the spleen, and generally absent in the lymph nodes and bone 
marrow, whereas conventional B2 cells are the predominant B cells type in 
the spleen and lymph nodes. B-1 cells have characteristics of activated 
cells, they are larger and more granular. Their Vh and VK repertoires differ 
considerably from those of conventional B cells. High frequencies of B 1 B 
cells are polyreactive and autoreactive. These include B cells specific for 
single-stranded DNA, rheumatoid factor, phosphatidyl choline and also 
includes B cells specific for bacterial carbohydrate antigens and phosphoryl
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choline, prompting B1 cells for T independent response to common bacterial 
antigens (Tatu et al, 1999).
B1 cell development and maintenance appear to depend on BCR 
signaling, because a reduction of B1 cell numbers occurs if there is 
insufficient BCR signaling or insufficient antigen stimulation. With the use of 
knock outs and transgenic mice it is possible to analyse this phenotype, 
although most of the studies were done in adult mice and the defect in 
signaling may act at several stages: from pre-B to mature B cell (Hardy et al, 
2001).
Engagement of the BCR activates cytoplasmic protein tyrosine 
kinases such as Syk, Lyn, Blk and Bruton's tyrosine kinase (Btk), and can 
lead to a multitude of cellular responses, such as proliferation, activation, 
differentiation or cell death. It has been demonstrated that adaptor proteins 
play a major role in interfacing tyrosine kinase activation by lymphocyte 
antigen receptors with selective downstream signaling molecules. One such 
adaptor molecule termed BLNK, SLP-65 or BASH has been identified in B 
cells and is specifically involved in BCR signaling. BLNK can associate with 
Btk and also couple Syk and VAV, and is intimately associated with 
intracellular calcium mobilisation, which is essential for cell activation. 
Phosphoinositide 3-kinase (PI3-kinase) is responsible for the production of 
phosphatidylinositol-trisphosphate and participates in various signal 
transduction pathways (Xu et al, 2000). The hematopoietic protooncogene 
VAV proteins belong to the DBL family of RHO guanine nucleotide exchange
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factors (GEFs) and are known to have an important role in regulating early 
events in receptor signaling (Tarakhovsky et al, 1995 and Zhang et al, 
1995).
When mice are made deficient for different molecules that regulate 
signaling through BCR, the number of B1 cells are likely to be reduced. 
Various examples can be found in the literature, such as CD19 a BCR co­
stimulatory transmembrane protein (Inaoki et al, 1997), the BLNK/SLP-65 
adaptor protein (Xu et al, 2000), the Cr2 gene encoded CD21 molecule that 
complexes with CD19 (Carroll et al, 1998), VAV (Tarakhovsky et al, 1995 
and Zhang et al, 1995), the PI3-kinase (Suzuki et al, 1999 and Fruman et al,
1999) and the Btk tyrosine kinase (Khan et al, 1995) knockout mice all have 
decreased numbers of CD5+B cells. Since most of these factors are known 
to play roles in BCR mediated activation, the decrease in CD5+ B cells have 
been attributed to disruption of activation-mediated upregulation of CD5 
expression on B cells (Hardy and Hayakawa, 2001). Knockout cyclin D2 
mice, show a defect on cell cycle progression and also have a decrease in 
CD5+ B cells (Solvason et al, 2000).
Transgenic mice with BCRs of restricted specificity show, depending 
on the specificity, increased numbers of CD5+ B cells; 3H9ji-TG, M54p-TG 
3-83n6-TG, specific to H-2KkDk, have decreased numbers of CD5+ B cells, 
and VH11p-TG, specific to phosphorylcholine (Chumley et al, 2000), VH12p- 
TG also specific to phosphorylcholine, and VH3609p-TG (Hayakawa et al, 
1990) have their numbers of CD5+ B cells increased. This difference is
48
Introduction
explained by the fact that peritoneal B1 B cells are positively selected by 
self-antigens.
BCR-mediated signaling is also controlled by negative regulators, 
such as the CD22 BCR adaptor molecule. The src family kinase, Lyn, based 
on its capacity to phosphorylate the inhibitory receptors FcRllb or CD22. 
PD-1, an immunoglobulin superfamily member with an ITIM motif. SHP-1, a 
protein-tyrosine phosphatase with two src-homology 2 domains. FcRllb, 
CD22 and PD-1 can recruit SHP-1 protein tyrosine phosphatase that can 
play a major role in negative signalling.
In mice with strengthened BCR signal there is an increased number 
of CD5+ cells. It was observed on SHP-1 mutant (me) (Sidman et al, 1986) 
and CD19-TG (Sato et al, 1996b). CD22, lyn and PD-1 knockout mice all 
have an increased number of B1b B cells (Chan et al, 1997, Nishizumi et al, 
1995 and Wang et al, 1996). The increase in B-1b cells in CD22-, lyn-, or 
PD-1-deficient adult animals might be due to a breakdown in tolerance 
during B-2 development, since adult bone marrow cells can generate B-1b 
type cells (Hardy and Hayakawa, 2001).
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Similarities between MZ and B1 B cells
Alterations in some molecules that affect B cell signaling result in 
parallel changes in MZ and B1 B cells. B cells with diminished BCR 
signaling, including CD45, CD19, CD21 and PI3K6 deficient mice, lack MZ 
and B1 B cells (Rickert et al, 1995, Sato et al, 1996b, Ahearn et al, 1996, 
Martin and Kearney, 2000 and Clayton et al, 2002), and mice with enhanced 
B cell signaling such as mice lacking PTEN, a negative regulator of PI3K are 
characterised by enhanced numbers of MZ and B1 B cells (Anzelon et al, 
2003). Other examples demonstrate that these two B cell subsets are not 
always regulated in tandem such as CD22 deficient mice where B1 cells are 
increased but MZ cells are reduced (O'Keefe et al, 1996, Sato et al, 1996a 
and Samardzic et al, 2002), though one group showed no change in B1 cell 
numbers (Otibody et al, 1996).
Marginal zone (MZ) and B1 B cells have been implicated in the rapid, 
early response to infection, T-independent response, in autoimmunity and 
lymphogenesis (Hayakawa and Hardy, 2000, Martin and Kearney, 2001 and 
Morse et al, 2001). For example, NZB/W lupus prone mice have an 
elevated proportion of B1 and MZ B cells (Wither et al, 2000).
These two population are also targets of positive selection, this 
viewpoint was demonstrated by Cyster and Good now, who showed that 
CD45 deficient cells can only enter the long lived B cell pool if exposed to 
well defined, transgene encoded self-antigens (Cyster et al, 1996). MZ and 
B1 B cells have a repertoire biased by positive selection, where MZ are
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enriched with B cells expressing the phosphoryl choline binding idiotype 
M167 or fetal associated idiotype 81X, but not B cells specific for hen 
lysozyme (Martin and Kearney, 2000) and B1 B cells are enriched with cells 
specific for single-stranded DNA, rheumatoid factor and phosphatidyl choline 
(Tatu et al, 1999).
Table 4 shows similarities and differences between MZ and B1 B cell, 
as well as T1, T2 and follicular B cells and table 5 shows the effect of 
mutations in molecules that are important for the development of B cells.
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Table 4. Comparison of phenotype and function of B cell subsets.
Phenotype B1
lgMhi9h
IgD10"
CD2110"
CD23neg
CD5+
T1
lgMhigh
lgDl0W
CD21low
CD23neg
T2
lgMhi9h
lgDhiQh
CD21hi9h
CD23pos
MZ
lgMhi9h
lgDl0W
CD21hi9h
CD23ne9
FO
lgMlow
lgDhlgh
CD21inter
CD23high
Half-life Long Short Short Long Long
Blood circulation + ++ - - +
Lymph circulation - - - - +
Tl responses +++ - +++ +++ +
TD responses +/- - - + +
Ag presentation in vitro +++ - + +++ +
Time to peak cell cycle Short Long Short Short Long
Apoptosis after anti-IgM - +++ + +++ +
BCR positive selection 
Proliferation
++ ++ ++ +/-
LPS +++ - + ++ -
LPS+IgM NA - +++ +++ +++
CD40 ++ + + ++ +
igM - - +/- - +
lgM+CD40 ++ + + ++ ++
Adapted from Martin and Kearney, 2002 and Su et al, 2004
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Table 5. Mutations in molecules that affect B cell development
Mutation Observations References
Aiolos Reduction of MZ and B1 B cells Cariappa et al, 2001
Baff Developmental arrest at the T2 to 
mature B cell development
Schiemann et al, 2001
Baff-R Developmental arrest at the T2 to 
mature B cell development
Thompson et al, 2001
BLNK Reduction of B1 B cells Xu et al, 2000, Pappu et 
al, 1999
Btk Developmental arrest at the T2 to 
mature B cell development
Martin and Kearney, 
2000, Petro et al, 2000, 
Bajpai et al, 2000
CD19 Reduction of MZ and B1 B cells Martin and Kearney, 
2000, Inaoki et al, 1997
CD21 Reduction of MZ and B1 B cells Carroll et al, 1998, 
Cariappa et al, 2001
CD22 Increased B1 B cells and MZ B cells 
are reduced
Chan et al, 1997, 
O’Keefe et al, 1996, 
Sato et al, 1996a, 
Samardzic et al, 2002
CD45 Reduction of MZ and B1 B cells Cyster et al, 1996
Cyclin D2 Reduction of B1 B cells Solvason et al, 2000
iga Developmental arrest at the T1 
stage of B cell development
Torres et al, 1996
Iga with 
mutations 
in the 
ITAM
Reduction of MZ B cells Kraus et al, 2001
Lyn Reduction of MZ B cells and 
increased B1 B cells
Seo et al, 2001, 
Nishizumi et al, 1995
Notch 2 Fail to generate MZ B cells Allman et al, 2002
PD-1 Increased B1 B cells Wang et al, 1996
PI3K Reduction of MZ and B1 B cells Suzuki et al, 1999, 
Fruman et al, 1999
PKCp Developmental arrest at the T2 to 
mature B cell development
Leitges et al, 1996, 
Saijo et al, 2002
PLCy2 Developmental arrest at the T2 to 
mature B cell development
Wang et al, 2000
PTEN Increased B1 and MZ B cells Anzelon et al, 2003
SHP-1 Increased B1 B cells Sidman et al, 1986
VAV Reduction of MZ and B1 B cells Tarakhovsky et al 1995, 
Zhang et al, 1995
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T independent response
Although peptide-specific helper T cells are required for B cell 
responses to protein antigens, many microbial constituents, such as 
bacterial polysaccharides, can induce antibody production in the absence of 
helper T cells. These microbial antigens are known as thymus-independent 
or Tl antigens. The signal required to activate antibody production to Tl 
antigens is either provided directly by recognition of a common microbial 
constituent, or by a non thymus-derived accessory cell in conjunction with 
massive cross-linking of B cell receptors, which would occur when a B cell 
binds repeating epitopes on the bacterial cell. Thymus independent 
antibody responses provide some protection against some extracellular 
bacteria.
TI-1 antigens possess an intrinsic activity that can directly induce B- 
cell division. At high concentration, these molecules cause proliferation and 
differentiation of most B cells regardless of their antigen specificity. An 
example of a B-cell mitogen and TI-1 antigen is LPS.
Another class of thymus-independent antigens consists of molecules 
such as bacterial capsular polysaccharides that have highly repetitive 
structures. These thymus-independent antigens (TI-2 antigens) contain no 
intrinsic B cell stimulating activity. TI-1 antigens can activate both immature 
and mature B cells, TI-2 antigens can activate only mature B cells.
54
Introduction
Responses to several TI-2 antigens are common among B-1 cells and 
marginal zone B cells.
TI-2 antigens act by extensively cross-linking the B-cell receptors of 
mature B cells specific for the antigen. Excessive receptor cross-linking 
makes immature and mature B cells unresponsive or anergic (Janeway et al, 
2001 and Shih et al, 2002).
IgM deficient mice
Natural serum IgM provides the first defence against infection and 
accelerates the development of the primary immune response. Mice 
deficient in serum IgM were more susceptible to peritonitis induced by cecal 
ligation and puncture. This susceptibility was due to the reduced level of 
TNFa and a decrease in neutrophil recruitment causing an increase of 
bacterial load in the peritoneum (Boes et al, 1998b). IgM deficient mice also 
show significantly reduced viral clearance and survival when infected with 
influenza virus (Baumgarth et al, 2000). It is clear that serum IgM is an 
important source of natural antibody and act as the first barrier to viral and 
bacterial infection.
A mutant mouse that does not secrete IgM, but still expresses 
membrane bound IgM, was made by deleting the Cp secretory tailpiece and 
the pS polyadenylation site by Lox/Cre gene mediated gene targeting. 
These mice have normal levels of all Ig isotypes, apart from IgM, which is
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absent in the serum. B cell proliferation is normal in response to LPS or IL4 
and anti-lgM. They show an elevated number of B1 B cells in the 
peritoneum. The T cell independent response to NP-Ficoll is increased, but 
reduced to T dependent antigens such as phOx-CSA (Ehrenstein et al, 
1998). These mice have an increased predisposition to develop IgG anti- 
DNA antibodies and renal deposition of IgG and complement with age. 
When immunised with LPS, IgM deficient mice show an augmented anti- 
DNA response (Ehrenstein et al, 2000). This suggests that the lack of 
serum IgM may influence the development of autoimmunity.
Another group also made a secretory IgM deficient mouse by 
targeting the ps exon and its three downstream polyadenylation sites and 
then replacing it by a cDNA fragment encoding the Cp4 and pm exons. Their 
findings were very similar, but elevated levels of lgG2a, lgG3, and IgA were 
observed in the mutant mice at an early age (Boes et al, 1998a).
Boes and colleagues also demonstrated the development of 
autoimmunity in IgM deficient mice. They crossed IgM mutant mice onto a 
lupus-prone lymphoproliferative (Ipr) mice bred into a MRL background. 
MRL/lpr mice spontaneously develop autoimmunity characterised by high 
levels of anti-DNA antibody and glomerulonephritis (Theofilopoulos and 
Dixon, 1985). Lpr is a mutation in the Fas (CD95) gene, a member of the 
tumor necrosis factor receptor family, and binding of the ligand, Fas-L, which 
triggers apoptosis in many cell types. The failure of apoptosis by Ipr 
mutation results in lymphoproliferative disease, including the emergence of
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oligoclonally expanded, autoreactive B cells bearing somatically mutated 
IgGs (Shlomchik et al, 1987 and Watanabe-Fukunaga et al, 1992).
In lupus-prone mice, the absence of secreted IgM accelerated the 
development of IgG autoantibodies and glomerolonephritis, and the mice 
succumbed to disease at an earlier age (Boes et al, 2000).
Another approach was used by (Chan et al, 1999) with MRL/pr mice 
expressing a mutant transgene encoding surface immunoglobulin, but which 
did not permit the secretion of circulating Ig. These mice develop nephritis, 
characterised by cellular infiltration within the kidney, indicating that B cells 
without the production of antibodies, act as either antigen-presenting cells 
for autoreactive T cells, and/or by contributing to the inflammation site, exert 
a pathogenic role.
To test the role of Fas in the elimination of defective B cells, Melamed 
et al, 2000, introduced the Ipr mutation to mice lacking the IgM 
transmembrane tail exons, in which B cell development is blocked at the pro- 
B stage. They showed that these mice developed significantly enhanced 
autoimmunity and autoantibody production mainly because the absence of 
functional Fas allowed for defective B cells to be generated and selected to 
participate in the autoimmune process.
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The influence o f genetic background in autoimmunity
Autoimmune diseases are complex disorders characterized by 
adaptive immune response that are inappropriately directed against self 
tissues. Systemic lupus erythematosus (SLE) is an autoimmune disease 
characterised by elevated levels of IgG antinuclear antibodies and the 
development of an immune-complex mediated glomerulunephritis (Kotzin 
1996). The genetic background seems to play an important role in the 
development of autoimmunity.
New Zealand black (NZB) mice are one of the best known models of 
lupus, it is not sex linked and they spontaneously develop haemolytic 
anaemia, glomerulonephritis and lymphomas. NZB when crossed with NZW 
(New Zealand white) mice have a progeny called NZB/W (New Zealand 
black white) mice, where the females spontaneously develop a lupus like 
disease characterized by severe immuno-complex nephritis (Theofilopoulos 
and Dixon 1985).
Female MRL//pr mice develop a fatal immune-complex 
glomerulunephritis at an early age, and both sexes develop a very severe 
lymphoproliferation (Ipr). MRL+/+ develop a similar, but milder and with a 
later onset form of lupus. In contrast the Ipr gene in other strains such as 
C57BL/6 leads only to autoantibody production (Izui et al, 1984).
The BXSB is a recombinant inbred strain resulting from crossing 
C57BL/6J females with SB/le males. It is an unique model as the males
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develop the most severe form of the disease, which is characterised by 
haemolytic anaemia, lymphoadenopathy and glomerulonephritis (Izui et al, 
1995).
Genetic mapping has identified multiple intervals associated with 
disease susceptibility. The majority of the intervals detected are strain 
specific, confirming the genetic complexity of the disease and indicating the 
presence of extensive heterogeneity in the genes contributing to the 
pathogenesis of the disease. However, loci on distal Chromosome 1 have 
been found on both NZ and BXSB model indicating that some susceptibility 
may be shared amongst lupus prone strains (Wakeland et al, 2001).
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HYPOTHESIS
Serum IgM has multiple functions in the immune system. It is 
proposed that serum IgM by virtue of its polyreactivity can boost signals 
delivered via the BCR. It is thought that the strength of BCR signalling can 
regulate the selection of B cell subsets, and thus natural IgM may play a role 
by forming complexes with (auto)antigens to make them more immunogenic. 
The hypothesis to be tested is that lack of serum IgM alters the 
regulation/selection of B cell subsets.
IgM has also been shown to be important in autoimmunity and it is 
proposed that lack of serum IgM would lead to increased autoimmunity in an 
autoimmune predisposed mouse strain.
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AIMS
1) To characterise the changes in B cell subsets in mice deficient in 
serum IgM.
2) To characterise the cause of the changes in B cell subsets in mice 
deficient in serum IgM.
3) To investigate the mechanisms that underlie the alterations in the B 
cell subsets by reconstituting serum IgM deficient mice with polyclonal 
or monoclonal IgM.
4) To analyse the T-independent immune response in serum IgM 
deficient mice and determine the serological and cellular responses 
when different forms of IgM are administered at the same time as the 
antigen.
5) To investigate further the relationship between deficiency of serum 
IgM and autoimmunity by intercrossing the serum IgM deficient mice 
with the mild autoimmune strain BL/6 Ipr mice.
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MATERIALS AND METHODS 
Mice 
Breeding of Su- mice
The generation of Sp- mice has been described previously 
(Ehrenstein et. al, 1998). Mice were backcrossed onto C57BL/6 for 6 
generations and kept under specific-pathogen-free conditions. Spi- and litter 
matched controls mice used for the experiments were 3-12 month old. PCR 
and ELISA were performed to ensure that IgM was not being secreted.
Generation and breeding of Vu1s mice
The Vp1 construct (kind gift from Dr Michael Neuberger, Laboratory of 
Molecular Biology, Cambridge, UK) encodes a VH (a allotype) gene, which 
binds to (4-hydroxy-3-nitrophenylacetyl - NP), under control of a VH 
promoter (Sitia et. al, 1990). It was modified by restriction enzyme digestion 
(Cla I site upstream of the VH promoter to Kpn which is 1 Kb 3’ of the ps poly 
A site but 5’ of the pM1 splice acceptor site). The membrane exon of the 
transgene was therefore deleted but the secretory exon remained intact. 
The resulting 11 kb construct Vp1s (Figure 7A) was used for pronuclear 
injection and transgenic mice were generated by standard techniques (UCL- 
Gene Targeting and Transgenic Core Facility). The mice were tested for the 
presence of the transgene by PCR, the expression of IgM in the serum by
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ELISA and FACs was used to ensure that there was no B cell membrane 
transgene expression. These mice were backcrossed 6 times onto C57BL/6 
mice and subsequently onto Sp- mice.
Breeding of Su- onto C57BL/6 /or mice
Serum IgM deficient mice were intercrossed onto a C57BL/6 mice 
homozygous for the Ipr mutation of Fas (CD95). Mice were kept under 
specific-pathogen-free conditions. Sp-, Ipr; Sp- Ipr and litter matched 
controls mice were 3-12 month old. PCR was performed to ensure that the 
mice were Fas mutant (Singer and Abbas 1994).
Genotyping 
Preparation of genomic DNA
Tail tip biopsies of mice were placed in 500pl of tail buffer (100mM 
Tris pH8.5, 5mM EDTA, 0.2% SDS and 200mM NaCI-Sigma) plus 35pl of 
10mg/ml proteinase K (Sigma), and the tissue was digested over night at 
55°C. The digested tissue was extracted using the same volume of 
equilibrated phenol (USB) and the aqueous supernatant was again extracted 
using the same volume of 24:1 of chloroform and isoamylalcohol (BDH). 
The DNA was precipitated with 0.8 volumes of isopropanol (BDH), the 
precipitated DNA was washed with 70% ethanol (BDH) and air dried before 
being redissolved in 200ul of purified water (Sigma).
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PCR for genotvping Si*-. Vu1s and lor mice
PCR was routinely carried out using PCR thermalcycler (Biometra) in 
accordance with the manufactures’ instructions. Genotyping was performed 
using 1 pi of genomic DNA from tail tip biopsies. Taq polymerase (Promega) 
was used for genotyping Vp1s and Ipr, and TaqPlus Long (Stratagene) was 
used for Sp- according to the manufactures’ instructions. Oligonucleotides 
were produced by MWG and used at concentration of 100ng/pl. The 
fragments were analysed on agarose (Sigma) gels containing ethidium 
bromide (Sigma).
Primers used for genotyping 
Sp- mice
5’ cct tac ttc ctg aag gac teg g 
5’ eta gag gca tct etc cct gtc 
Vp1s mice
5’ tat gta tcc tgc tea tga at 
5’ ttt taa gga etc acc tga gg 
Ipr mice
5’ aat aat tgt get teg tea g 
5’ tag aaa ggt gca egg gtg tg 
5’ caa ate tag gca tta aca gtg
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Injections and immunisation
Injection of IgM polyclonal and monoclonal
Sp- and litter matched controls were injected i.p. 3x a week for 2 
weeks with 200pg/mouse (concentration of serum IgM in wild type mice) of a 
purified monoclonal (either TEPC-183, unknown specificity (here designated 
monoclonal A) or MOPC-104E, specific for -1,3-glucose (here designated 
monoclonal B) from Sigma or a polyclonal IgM antibody from Rockland. The 
antibodies were chosen according to availability in the market.
Immunisation with PC-Ficoll
The hapten PC-Ficoll was chosen because it does not bind to the 
transgene Vp1s like NP, and specifically stimulates marginal zone B cells 
and not B1 B cells. To determine the T independent response against 
phosphorylcholine hydroxyphenylactic acid (PC)-Ficoll (Bioresearch 
Technologies), mice were immunised i.p. with 10ptg of PC-Ficoll in PBS. Sp-, 
Vp1s, Sp- mono, Sp- poly and litter matched controls were bled via the tail 
vein on day 0, 7 and day 14 after immunisation.
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Im munoassays 
ELISA for serum IgM
The titres of IgM in the serum of S\i-, Vp1s, Sfx- mono, S\i- poly and 
litter matched control were performed on NUNC maxisorp plates. The wells 
were coated for 2 hours with 2pg/ml of purified anti-mouse IgM (11/41) 
(Pharmingen) diluted in PBS (1L of 10x PBS: KCI 2g, KH2P04 2g, Na2HP04 
11.48g, NaCI 80g - Sigma) and blocked overnight at 4°C with PBS/2%BSA 
(Serum albumin bovine -  Sigma). 1jil of serum was added in serial dilutions. 
2pg/ml of biotinylated rat anti-mouse IgM (R6-60.2) was used when 
measuring total IgM, when measuring the V^ils transgene and the amount of 
IgM after the mono or poly injections IgMa (DS-1) (Pharmingen) was used 
as secondary antibody. The bound antibodies were detected using 
streptavidin-horseradish peroxidase (HRP) from Dako and developed by 
ABTS (Sigma) in 20ml H20 , 0.5ml 1M Na Citrat, 0.5ml 1M Citric Acid and 4ptl 
H20 2. PBS/0.5% tween 20 (Sigma) was used to wash the plates between 
each step. Known concentrations of purified IgM (MOPC-104E Sigma) 
antibody was used to calculate the dilution curves. Plates were read at 409 
nm (Anthos HTII).
ELISA anti-phosphorvlcholine (PC) Ficoll
ELISA was performed to measure lgG3, (IgM and lgG3 are the main 
antibodies produced in T-independent responses, in the absence of IgM,
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lgG3 was measured) anti-phosphorylcholine (PC) Ficoll on NUNC maxisorp 
plates. The wells were coated for 2 hours with 10pg/ml of PC-BSA 
(Bioresearch Technologies) diluted in PBS and blocked overnight at 4°C with 
PBS/2%BSA. 1pl of serum, from mice bled on day 0, 7 and 14 after IgM 
injection, was added in serial dilutions. 2pg/ml of biotinylated rat anti-mouse 
lgG3 (R40-82) from Pharmingen was used as the secondary antibody. The 
bound antibodies were detected using streptavidin-horseradish peroxidase 
(HRP) from Dako and developed by ABTS (Sigma). Plates were read at 409 
nm (Anthos HTII).
The monoclonal and polyclonal IgM antibodies that were used for 
injections were tested against phosphorylcholine to detect specific binding 
using biotinylated rat anti-mouse IgM (R6-60.2) from Pharmingen as 
secondary antibody.
ELISA anti-dsPNA
Sp-, Ipr, Sp- Ipr and litter matched controls were bled via the tail vein 
at intervals of 4 weeks for 12 months to follow the development of IgG anti­
double stranded (dsDNA) antibodies.
NUNC maxisorp plates were pre coated for 2 hours with 2.5pg/ml of 
poly-L-Lysine (Sigma) diluted in distilled water and coated for 2 hours with 
0.1pg/ml of dsDNA diluted in PBS and blocked overnight at 4°C with 
PBS/2%BSA. 1 pi of serum was added in serial dilutions. 2pg/ml of goat 
anti-mouse IgG conjugated to alkaline phosphatase (Southern
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Biotechnology Inc.) was used. The binding of antibodies to dsDNA was 
detected using phosphatase substrate PNPP (Sigma) dissolved in 
bicarbonate buffer pH 9.4 (1L: Sodium carbonate 0.8g, Sodium bicarbonate 
1.55g - Sigma). Plates were read at 409 nm (Anthos HTII).
The serum of a MRLIpr mouse known to have positive titres of IgG 
anti-dsDNA was used as the positive control and given value 1 Unit in all 
plates.
The monoclonal and polyclonal IgM antibodies that were used for 
injections were tested against dsDNA to detect specific binding as described 
above using goat anti-mouse IgM conjugated to alkaline phosphatase 
(Southern Biotechnology Inc.) as secondary antibody.
ELISA antl-histones
The monoclonal and polyclonal IgM antibodies that were used for 
injections were tested against histones to detect specific binding. NUNC 
maxisorp plates were coated over night at 4 °C with 10[xg/ml of histone type 
IIS (Sigma) diluted in PBS and blocked for 2 hours at room temperature with 
PBS/2%BSA, and any DNA contaminating the histone was removed by 
treatment with DNAse 1 (Sigma). V I  of serum was added in serial dilutions. 
2pg/ml of goat anti-mouse IgM conjugated to alkaline phosphatase 
(Southern Biotechnology Inc.) was used. The binding of antibodies to 
dsDNA was detected using phosphatase substrate PNPP (Sigma) dissolved 
in bicarbonate buffer pH 9.4. Plates were read at 409 nm (Anthos HTII).
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ELISA anti- myeloperoxidase (MPO)
The monoclonal and polyclonal IgM antibodies that were used for 
injections were tested against myeloperoxidase to detect specific binding. 
The myeloperoxidase ELISA was carried out using a Captia 
myeloperoxidase ELISA kit (Trinity Biotech, Bray, Ireland) in accordance 
with the manufactures’ instructions.
Cell isolation and cell culture
Sji-, V^ils, Sjx- mono, S i^- poly, Ipr, S^- Ipr and litter matched control 
peritoneal cells were isolated by flushing the peritoneal cavity with 2 ml of 
PBS supplemented with 0.2% fetal calf serum FCS (Gibco). Splenic and 
lymph node cell suspensions were prepared using mechanical disruption of 
the tissue and passed through a 70 ^m nylon mesh. Cell suspensions were 
made following lyses of erythrocytes using Pharm Lyse (Pharmingen).
For some experiments splenocytes were cultured in B cell medium 
(RPMI, 5% FCS, 2nM glutamine, 1mM pyruvate, 1x MEM non essential 
amino acids, 10 units penicillin and streptomycin, 0.1 mg/ml gentamycin and 
50uM 2ME - Gibco) alone or with 10ug/ml of F(ab')2 goat anti-mouse IgM 
(Southern Biotechnology Inc) at 37 °C 5% C 02 for 2 or 24 hours, before the 
cells were stained for surface markers.
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Flow cytometric analyses
Flow cytometric analyses were performed on Sp-, Vp1s, Sp- mono, 
Sp- poly, Ipr, Sp- Ipr and litter matched controls to determine the expression 
of cell surface markers. 1x106 splenic, lymph node or peritoneal cells were 
stained for 20 minutes with 0.5pg of the following conjugated monoclonal 
anti-mouse antibodies (Pharmingen):
Biotinylated Fluorescein Isothiocyanate (FITC) R-Phycoerythrin (R-PE)
CD23 (B3B4) IgM (R6-60.2) CD45R/B220 (RA3-6B2)
CD5 (53-7.3) CD3 (17A2) IgD (11-26c.2a)
IgMa (DS-1) CD21/CD35 (7G6) IgM (R6-60.2)
IgMb (AF6-78) CD19 (1D3)
IgD (11-26c.2a)
The cells were then washed with PBS/0.2%FCS and Cy5-conjugated 
to streptavidin (Dako) was added to biotinylated monoclonal antibodies 
followed by a further 20 minutes incubation and appropriate washes. 
Stained cells were analysed on FACs scan or BD-LSR and files were plotted 
using CELLQuest software both from BD Biosciences.
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Immunoflourescence staining o f tissue sections
Standard immunoflourescence staining procedures were used. OCT- 
embedded, snap-frozen spleens were sectioned at 8\im (Leica CM 1900), 
air-dried and acetone-fixed at 20 °C. The sections were blocked for 
nonspecific binding with PBS/2%FCS, stained with 10pig/ml of FITC 
conjugated anti-mouse IgM (R6-60.2) and biotinylated anti-mouse IgD (11- 
26c.2a) (Pharmingen), incubated for 2 hours at 4 °C in the dark followed by 
washes with PBS and Texas Red-conjugated to streptavidin (Dako) was 
added to biotinylated monoclonal antibodies and incubated for 2 hours at 
4°C in the dark followed by washes with PBS. Sections were mounted with 
VECTASHIELD (Vector). Sections were viewed (10x) with a Zeiss Axiovert 
100 TV fluorescence microscope equipped with filters of 488 and 568 nm for 
FITC and Texas Red respectively. Images were acquired and processed 
using cofocal assistant 4.02 (Todd Clark Brelje) and Abode Photoshop 4.0 
(Adobe).
In vivo 5-bromo-2'-deoxyuridine (BrdU) incorporation
In vivo 5-bromo-2'-deoxyuridine (BrdU) incorporation was used to 
access the turnover rate of B lymphocytes in the spleen and peritoneal 
cavity of four month old Sja- and litter matched control. Mice had BrdU (BD 
biosciences) through drinking water diluted to 0.8mg/ml every 12 h for 3 or 7
72
Materials and Methods
days. Spleen and peritoneal cells were stained for surface expression of 
CD23, CD21, IgM, IgD, CD5 and B220 using standard FACS techniques as 
described above, followed by fixation, permeabilisation, treatment of cells 
with DNase, intracellular staining for BrdU and flow cytometric analysis all 
performed according to the manufactures’ instructions (BrdU Flow Kit- 
Pharmingen). Cells were analysed on BD-LSR, and files were plotted using 
CELLQuest software both from BD Biosciences.
Apoptosis measured by terminal dUTP nucleotide end labelling 
(TUNEL)
The incorporation of FITC-dUTP into DNA strand breaks by the 
terminal dUTP nucleotide end labelling (TUNEL) method was used to 
determine apoptosis. Sp- and litter matched control 4-month-old mice were 
used for these experiments. Spleen and peritoneal cells were stained for 
surface expression of CD23, CD21, IgM, IgD, CD5 and B220 using standard 
FACS techniques as described above, followed by fixation, permeabilisation, 
labelling reaction with TUNEL and flow cytometric analysis was performed 
according to the manufactures’ instructions (In Situ Cell Death Detection Kit, 
Fluorescein-Roche). Cells were analysed on BD-LSR, and files were plotted 
using CELLQuest software both from BD Biosciences.
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Measurement o f intracellular calcium flux mobilisation
Spleen and peritoneal cells were stained for surface expression of 
CD23, CD21, CD5 and B220 using standard FACS techniques as described 
above, cells were loaded with lndo-1AM (Molecular Probes) for 1 hour at 
37°C. Cells were washed twice, resuspended at a concentration of 2 x 106 
cells/ml in RPMI and 5% FCS, and stimulated with Vg/ml up to 30pg/ml of 
F(ab')2 goat anti-mouse IgM (Southern Biotechnology) for few seconds. 
Calcium flux was measured by calculating the ratio of calcium bound indo-1 
(FL5) and unbound (FL4) versus time using a BD-LSR (BD Biosciences), 
which allows for 6 parameter flow cytometry including real time analysis of 
changes in UV fluorescence on gated populations. Data analysis was 
performed using CellQuest (BD Biosciences) and FloJo (Tree Star) software.
Statistical analyses
Means were compared by the Student's T Test and differences were 
considered significant when p value was < 0.05.
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RESULTS 
B cell development
Marginal zone B cells are expanded in serum IgM deficient (Su-) mice
Mature splenic B cells can be divided into marginal zone and follicular 
B cells and can be distinguished by surface markers using FACS. Marginal 
zone B cells are lgMhigh lgDl0W CD21high CD23neg and were expanded in 4- 
month-old Sp- mice whereas follicular B cells were reduced (Figure 7A). 
The increase in MZ B cell numbers was 2.5-fold, the reduction in follicular B 
cells was less (a 25% reduction) based on proportion of absolute cell 
numbers for individual mice. Wild-type (WT) and Sp- mice have the same 
number of splenic B220+ B lymphocytes (WT 1.27x107 ± 0.26, Sp- 
1.12x 107± 0.17). In older mice (12 month old) the MZ:FO B cell ratio was 
increased in WT mice and the difference in MZ:FO B cell ratio between Sp- 
and WT mice was less striking at this age (Figure 7B).
Spleen sections taken from naive 4 month old Sp- mice stained with 
anti-IgM and anti-lgD demonstrated a larger lgMbr,ght lgDdu" MZ area on the 
periphery of the follicle compared with WT controls, further demonstrating 
the expansion in MZ B cells in Sp- mice (Figure 8).
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Figure 7. Splenic B cell subsets in Sp- mice. (A) FACS analysis of spleen cells 
derived from Sp- and litter-matched control (4 and 12 months), stained with anti- 
6220, anti-CD21, and anti-CD23. The profiles are representative of results obtained 
from 6-10 mice and are gated on B220+ cells. (B) Histogram showing splenic 
MZ:FO B cell ratios calculated using absolute cell numbers in individual cell 
fractions. MZ and FO were defined from FACS analysis as illustrated in (A). (C) 
FACS plot showing T2 B cells, stained with anti-IgM and anti-lgD. * p<0.0002 in 
Student's T Test.
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Figure 8. Histology of Sp- mice spleens. The profiles are representative of 
results obtained from 6-10 mice 4 month old. Representative spleen sections 
derived from Sp- and litter matched control mouse stained with anti-IgM (green) and 
anti-lgD (red).
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Transitional type 1 B cells are expanded in Su- mice
Immature newly formed B cells (lgMhigh lgDl0W CD21|0W CD23neg), also 
known as T1 or fraction E (Loder et al, 1999; Hardy and Hayakawa, 2001) 
were expanded in Sp- mice (Figure 7A, 7C and Table 6), whereas the 
transitional subset identified as T2 (lgMhi9h lgDhi9h CD21hiflh CD23pos), 
remained unchanged in Sp- mice (Figure 7C and Table 6).
Polyclonal, but not monoclonal IgM or Vu1s transqene reverse the MZ 
B cell expansion
To determine whether polyclonal IgM is critical in governing the B cell 
compartments, two approaches were used. The first was to generate a 
transgenic mouse line (Vp1s, IgH a allotype) in which B lymphocytes 
secreted a p heavy chain, but the construct was engineered so that no 
transgene expression was detectable on the B cell surface (Figure 9A). 
These Vp1s transgenic mice were backcrossed onto C57BL/6 mice and 
subsequently onto Sp- mice to test whether MZ B cell expansion would be 
reversed. Consistent with the removal of the CpM exons, B lymphocyte 
membrane expression of the transgene was undetectable by FACS (Figure 
9B), but IgM (derived only from the transgene) was present in the serum of 
Sp- Vp1s mice (Figure 10). These mice would therefore have a secreted 
monoclonal repertoire generated by a number of light chains pairing with the 
single transgenic heavy chain.
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Table 6. Percentage of subpopulations of B cells in the spleen.
Naive WT W TV pIs WT mono WT poly Sp’ Sp’Vp1s Sp' mono Sp' poly
T1 10±2 9±2 8±3 12±4 19±4 19±3 18±2 14±3
T2 19±2 21±2 16±2 14±2 22±4 22±2 22±3 17±2
MZ 4±1 4±2 4±2 3±1 12±2 12±2 12±2 3±1
Mature 67±6 66±4 71 ±5 70±5 47±6 47±5 48±4 64±4
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Figure 9. Transgene construct of Vp1s. (A) The secretory p tailpiece (tp) and the ps 
polyadenylation site are located within the Vp1s construct; the p constant region (CpM) 
and the pm polyadenylation have been removed from the original Vp1 construct and 
are shown for information only. (B) FACS analysis of spleen cells taken from mice 
expressing the Vp1s transgene using IgM allotype-specific markers. The IgM allotype 
of the Vp1s transgene and the targeted Sp- allele are a, whereas the C57BL/6 allotype 
is b.
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Figure 10. IgM serum concentration. Titers of serum IgM in S|i- Vfils 
mice and in mice that had received a polyclonal (poly) preparation or two 
monoclonal (mono A, mono B) preparations of purified IgM measured 2 
days after the final injection of the different IgM preparations (three mice 
per group). Samples taken 1 or 2 days after each injection were not 
significantly different from results shown (data not shown). Full circle 
IgMb allotype; Empty circle IgMa allotype.
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The second method of replacing IgM was to administer a polyclonal 
preparation of IgM or two IgM monoclonals (mono A and mono B) i.p. every 
3 days for 2 weeks. The serum concentration of these preparations during 
the 2 week period was identical (Figure 10). However, the levels of serum 
IgM obtained following the administration of IgM were only 10% of normal 
and fluctuated relative to the day of injection. In the Sp- Vp1s mice serum 
IgM was slightly above that found with the injected preparations although the 
secretion was continuous rather than intermittent as dictated by the time of 
injections (Figure 10).
The main conclusion from these series of IgM replacement 
experiments is that only the polyclonal IgM preparation returned the 
increased splenic MZ:FO B cell ratio found in Sp- mice back to that observed 
in control mice as shown by FACS (Figure 11A and 11B) and tissue staining 
(Figure 10). The increased IgM staining on the periphery of the follicle seen 
in Sp- mice was restored to control levels by the administration of polyclonal 
IgM but not by the other monoclonals or in Vp1 Sp- mice (Figure 12).
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Figure 11. Polyclonal, but not monoclonal IgM or Vp1s transgene reverse 
the MZ B cell expansion. (A) Representative density plots to define proportion 
of MZ and FO cells using CD21 and CD23 as markers after administration of 
monoclonal A, monoclonal B, and polyclonal IgM (poly) and in S|i-Vp1s mice. 
The density plots shown are gated on B220+ B cells. (B) Histogram showing 
splenic MZ:FO B cell ratio calculated using absolute cell numbers in individual 
cell fractions as shown in (A). MZ and FO were defined from FACS analysis, 
each bar represents the mean of six mice ± SD. * p<0.0002 in Student's T Test.
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Figure 12. Histology of treated mice. Representative spleen sections 
derived from Sp- mice treated with monoclonal B or polyclonal IgM stained 
with anti-IgM (FITC, green) and anti-lgD (Texas Red, red). All mice were 
between 3 and 4 month old.
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Polyclonal, but not monoclonal IgM or Vu1s transgene partially reverse 
the T1 B cell expansion
Figure 11A demonstrates that after two weeks of treatment with the 
polyclonal or monoclonal IgM preparation, the expanded newly formed (T1) 
B cell population found in Sp- mice was only partially reversed by polyclonal 
IgM whereas the monoclonal preparation or Vp1s transgene had no effect in 
this subset of immature B cells (Table 6).
Polyclonal, but not monoclonal IgM or Vu1s reverses the peritoneal B1 
B cell expansion
B1 B cells were identified by FACS using anti-IgM, ant-B220 and anti- 
CD5. Consistent with previous observations (Ehrenstein et. al, 1998), 
peritoneal B1a cells were increased in Sp- mice. The expansion in B1 cells 
were reversed by polyclonal IgM but not in Sp- mice expressing the Vp1s 
transgene or the mice that had received the monoclonal IgM preparation 
(Figure 13A). The ratio CD5+:CD5- was calculated using absolute numbers 
of cells in each population (Figure 13B). Thus in this system B1 cells 
behaved in the same way as the marginal zone B cells.
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Figure 13. B1 peritoneal B cells. (A) FACS analysis of peritoneal cells gated 
on B220+ lymphocytes. (B) Histogram of CD5+ peritoneal B cells in naive mice. 
Numbers refer to the mean percentage of total B cells in each gate. The 
CD5+:CD5- ratio was calculated using absolute cell numbers from peritoneal 
washes in each group. Mono, monoclonal; poly, polyclonal. * p<0.0007 and ** 
p<0.0001 in Student's T Test.
87
Results
Polyclonal laM is polvreactive
To determine whether the reactivity of the different IgM preparations 
was associated with their ability to influence MZ and B1 cells, the binding to 
four different antigens (Ags) was assayed. Analysis of the binding of these 
IgM preparations to the Ags tested confirmed the multi reactivity of polyclonal 
IgM which bound all four Ags strongly, monoclonal A bound two Ags 
strongly, whereas monoclonal B bound only one Ag (Figure 14). Thus, the 
Ag reactivity of the IgM preparations correlated with their ability to reverse 
the changes in B cell subsets found in Sp- mice.
Su- follicular B cells have a higher rate of turnover than WT
In order to understand why the follicular B cell subset is reduced in 
Sp- mice compared to WT and the marginal zone B cells are expanded in 
Sp- mice compared to WT, cell cycling and apoptosis were measured. 
These techniques help to explain the homeostasis of B cells in a 
compartment that lacks serum IgM, thus showing its importance in the 
maintenance and selection of B cells in the periphery.
In vivo 5-bromo-2'-deoxyuridine (BrdU) incorporation was used to 
access the turnover rate of B lymphocytes in the spleen of 4 month old Sp- 
mice and controls. Splenocytes were gated on B220 for B cells and then 
subdivided into follicular, marginal zone, transitional type 2, transitional type 
1 B cells using anti-CD23, anti-CD21, anti-IgM and anti-lgD and all groups
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Figure 14. Reactivity of the three IgM preparations to PC, dsDNA, 
myeloperoxidase (MPO), and histones. Units were calculated using a 
serum from a 7 month old female NZB/W mouse as a reference, except 
for PC in which the positive control was a serum derived from a mouse 
immunized with PC. Mono, monoclonal; poly, polyclonal.
89
Results
were stained for anti-Brdll. BrdU was administrated orally every 12 hours 
for 7, 14 days or administrated for 3 days following by a 14 day interval 
before harvesting the cells (pulse chase).
Figure 15 demonstrates that the follicular B cells in the Sp- mice have 
a higher rate of turnover of cells than the control mice when these cells have 
been exposed to BrdU for 14 days. Marginal zone, T2, T1 and B1 B cells 
from Sp- mice have similar turnover rates of cells from the WT mice. These 
results suggest that follicular B cells, but not the other B cell populations are 
sensitive to the loss of serum IgM.
Su- peritoneal B1 B cells have a lower rate of turnover than WT
In vivo BrdU incorporation was used to access the turn over rate of B 
lymphocytes in the peritoneum cavity of 4 month old Sp- mice and controls. 
Cells from the peritoneal cavity were gated on B220 for B cells and then 
subdivided in 2 different groups. CD5+lgM+ for B1 B cells and lgM+CD5- for 
B2 B cells and all groups were stained for anti-BrdU.
Figure 16 shows that a reduction of BrdU incorporation was seen in 
B1 B cell after 14 days of continuous administration of BrdU in the Sp- mice. 
These mice have a higher number of B1 B cells in the peritoneal cavity when 
compared to WT, thus these results showed that these cells are not cycling 
as much, and probably remain in the peritoneal cavity longer. A strong 
positive signal via IgM is probably needed for B1 B cells to enter and
90
Follicular Marginal ZoneB cells
4 0 -
D  2 0 -
C 60 Transitional type 1 Transitional type 2
4 0 -
5  2 0 -
WT
sn-
Figure 15. BrdU incorporation in splenic B cells. Turnover of B cells, 
follicular, marginal zone, tansitional type 2, transitional type 1 and B1 B cells. 
Splenocytes of 4 month old Sp- and control mice were stained with anti-CD21, 
anti-CD23, anti-IgM, anti-lgD, anti-CD5 and anti-BrdU. B cells were gated 
using anti-B220. BrdU was administrated orally every 12 hours for 7, 14 or 
administrated for 3 days followed by a 14 day interval before harvesting the 
cells (pulse chase). Each point represents the mean of 4 mice ± SD. 
*p<0.001 in Student’s T Test.
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Figure 16. BrdU incorporation in peritoneal B cells. Turnover of B1 and 
B2 B cells. Cells from the peritoneal cavity of 4 month old Sp- and control 
mice were gated using anti-B220 for B cells, CD5+lgM+ for B1 B cells and 
lgM+CD5- for B2 B cells. BrdU was administrated orally every 12 hours for 7, 
14 or administrated for 3 days followed by a 14 day interval before harvesting 
the cells (pulse chase). Each point represents the mean of 4 mice ± SD. 
*p<0.0001 in Student's T Test.
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maintain proliferation, implying that natural IgM has different effects in 
different compartments as well as different populations of B cells.
Splenic Su- follicular B cells are dying more than the controls
The incorporation of FITC-dUTP into DNA strand breaks by the 
terminal dUTP nucleotide end labeling (TUNEL) method was used to 
determine apoptosis. Sp- and litter matched control 4-month-old mice were 
used for these experiments. Figure 17 shows that Sp- follicular B cells have 
statistically significant increased numbers of dUTP positive cells, indicating 
that these cells are entering apoptosis. Sp- follicular B cells are dying more 
than the WT, thus these results could explain why Sp- mice have less 
number of follicular B cells. There were no differences in the number of cells 
entering apoptosis in the other B cell subpopulations (MZ, T1, T2 and B1 B 
cells).
Su- peritoneal B1 B cells are dying less
The incorporation of FITC-dUTP into DNA strand breaks by the 
terminal dUTP nucleotide end labeling (TUNEL) method was used to 
determine apoptosis. Figure18 shows that peritoneal B1 B cells positive for 
IgM, CD5 and B220 have a decreased number of dUTP positive cells, 
indicating that these cells are entering apoptosis, but at a smaller extent 
than WT B1 B cells. The only statistically significant difference between the 
control and Sp- mice was found in the B1 B cell pool (Figure 18).
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Figure 17. Apoptosis in splenic B cells. 4-month-old Sp- and 
litter matched controls were labeled for the incorporation of FITC- 
dUTP into DNA strand breaks by the terminal dUTP nucleotide 
end labeling (TUNEL) by FACS. B cells, follicular, marginal zone, 
transitional type 1, transitional type 2 and B1 B cells were stained 
with anti-CD21, anti-CD23, anti-IgM, anti-lgD, anti-CD5 and anti- 
dUTP. B lymphocytes were gated on B220. Each bar represents 
the mean of 4 mice ± SD. *p<0.0001 in Student's T Test.
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Figure 18. Apoptosis in peritoneal B cells. 4-month-old Sp- and 
litter matched controls were labeled for the incorporation of FITC- 
dUTP into DNA strand breaks by the terminal dUTP nucleotide end 
labeling (TUNEL) by FACS. Cells from the peritoneal cavity were 
gated on B220 for B cells and then subdivided in 2 different groups. 
CD5+lgM+ for B1 B cells and lgM+CD5- for B2 B cells. Each bar 
represents the mean of 4 mice ± SD. *p<0.004 in Student's T Test.
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B1 B cells are behaving in a different way compared to B2 cells, they cycle 
and die less in the absence of serum IgM, whereas B2 cells in the spleen 
have a higher rate of cell turnover and apoptosis.
Calcium mobilisation following IgM cross-linking shows no differences 
between WT and Su- mice
CD21, CD23, CD5 and B220 markers were used to identify the B cell 
subtypes, as described above. Calcium flux was measured by calculating 
the ratio of calcium bound indo-1 (FL5) and unbound (FL4) versus time. 
Figure 19 shows that B cells when stimulated with agonist anti-IgM give rise 
to calcium responses. Splenocytes of 4 month old wild type and Sp- mice 
have the same pattern of calcium response when stimulated with different 
concentrations of anti-IgM ranging from 0.5ug/ml to 30ug/ml, figure 19 
showing results with 10ug/ml of anti-IgM. Subsets of B cells were analysed, 
MZ B cells have an increased response, whereas FO, T1, T2 and B1 B cells 
have about the same amount of calcium mobilisation.
Cells from the peritoneal cavity of 4 month old WT and Sp- mice 
stained for anti-B220 and anti-CD5 were also analysed and there was no 
difference in the amount of calcium mobilisation between the WT and Sp- 
mice when B1 and B2 B cells were compared (Figure 20). However, there 
were differences between B1 B cells resident in the peritoneum which 
showed hyporesponsiveness (no BCR mediated calcium response) and 
elevated basal calcium flux comparable to B2 B cells from the peritoneum or
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Figure 19. Calcium mobilisation following IgM cross-linking in splenic B cells.
CD21, CD23, CD5 and B220 markers were used to identify the B cell subtypes, as 
described before. Calcium flux was measured by calculating the ratio of calcium 
bound indo-1 (FL5) and unbound (FL4) versus time (200 seconds). Splenocytes of 4 
month old S(i- and litter matched control were stimulated with the agonist anti-IgM 
(fab2), at a concentration of 10ug/ml, few seconds before being analysed by FACS. 
The experiment was repeated 4 times giving consistent results.
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Figure 20. Calcium mobilisation following IgM cross-linking in 
peritoneal B cells. CD5 and B220 markers were used to identify the B1 
and B2 B cell. Calcium flux was measured by calculating the ratio of 
calcium bound indo-1 (FL5) and unbound (FL4) versus time (200 
seconds). Peritoneal lavage of 4 month old S\i- and litter matched 
control were stimulated with the agonist anti-IgM (fab2), at a 
concentration of 10ug/ml, few seconds before being analysed by FACS. 
The experiment was repeated 4 times giving consistent results.
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B1 B cells from the spleen. These results are representative of 4 
experiments.
BCR engagement drives the differentiation of T2 B cells into a mature 
B cell phenotype
There are differences in BCR responsiveness between the T1 and 12 
immature B cell subsets. T2 cells uniquely proliferate and survive in 
response to BCR cross-linking, consistent with a potential role in positive 
selection (Su et al, 2002, Batten et al, 2000 and Petro et al, 2002).
To address the developmental capacity of T2 B cells to differentiate in 
vitro into mature cells, BCR stimulation using anti-IgM fab2 was used. 
Splenocytes were incubated in media containing 10ug of anti-IgM for 2 hours 
and then these cells were analysed by FACS using CD21, CD23 and B220 
for B cells. Using these markers it is possible to identify 2 immature 
(transitional) populations and 2 mature (follicular and marginal zone).
Within 2 hours of BCR stimulation T2 B cells start to mature, as 
judged by the down regulation of CD21. Figure 21 shows the ratio of T2:FO 
calculated using the absolute number of cells, the number of cells decreased 
within 2 hours of BCR stimulation in the control and Sp- mice. No changes 
were found in the other B cell subsets. These results show that the WT as 
well as the Sp- T2 B cells are capable to mature in vitro upon BCR 
stimulation when identified using CD23, CD21 and B 220 as cell markers.
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Figure 21. BCR engagement drives the differentiation of T2 B 
ceils into a mature B cell phenotype. Splenocytes of 4 month 
old Sp- and litter matched control were incubated in media 
containing 10ug of anti-IgM (fab2) or media alone for 2 hours. 
Follicular and Transitional Type 2 B cells were stained with anti- 
CD21, anti-CD23 and anti-B220. The ratio of T2:FO was 
calculated using absolute cell numbers from each fraction derived 
from FACS analyses. Each bar represents the mean of 4 mice ± 
SD.
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BCR engagement drives B cells to blast normally
To confirm that B cells from S|j- mice were responding well to BCR 
stimulation, splenic cells were stimulated in vitro with a range of 
concentrations of anti-IgM (fab2) for 24 hours. Cells were harvested and 
analysed by FACs looking at the forward and sitter scatter (Figure 22). B 
cells from Sp- mice as well as the litter matched control were able to blast in 
response to BCR crosslinking.
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Figure 22. Blasting B cells cells upon BCR stimulation. Splenic 
cells were stimulated in vitro with media alone or media + anti-IgM 
(fab2) for 24 hours. Cells were harvested, and analysed by FACS. 
Two gates were made, one for blasting B cells and one for resting B 
cells, the numbers shown are the percentage of cells in each gate. 
The plots are representative of 4 experiments.
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T independent response
MZ B cells are further expanded in Su- mice in response to a T- 
independent antigen
The increased numbers of MZ B cells observed in S|j- mice is 
accentuated following intraperitoneal (i.p.) administration of the T- 
independent antigen PC-Ficoll (Figure 23). Consistent with the observation 
that PC-Ficoll selectively targets MZ B cells rather than B1 cells (Amlot et al, 
1985).
T cell independent response to PC-Ficoll
To determine whether polyclonal IgM could alter the increased MZ:FO 
ratio following immunisation, mice were injected with PC-Ficoll. The day 
following the injection either polyclonal or monoclonal IgM was administered 
for two weeks using the same protocol as described above. The increased 
lgG3 immune response seen in Sp- mice was partially reversed by the 
administration of polyclonal IgM (Figure 24A) and these changes paralleled 
the alterations in the MZ/FO B cell ratio (Figure 24B).
Table 7 shows the percentage of marginal zone, T1, T2 and 
follicular/mature B cells following immunisation with PC-Ficoll.
103
Table 7. Immunised mice with PC-Ficoll. Percentage of subpopulations of B cells in the spleen.
Immunised WT WT V(i1s WT mono WT poly Sji" Sp." Vp1s Sp' mono Sp' poly
T1 10±1 10±2 10±2 13±2 15±1 17+3 17±2 16±2
T2 21 ±2 28±4 22±2 18±3 27±1 29±3 20±2 18±3
MZ 7±1 8+1 4+2 4±2 16±2 15±3 13±2 9±3
Mature 61+3 58±2 63±3 68±3 41 ±4 38±4 49+3 57±7
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Figure 23. Splenic B cell subsets in immunised Sp- mice. FACS analysis of 
spleen cells derived from Sp- and litter-matched controls two weeks following 
immunisation with PC-Ficoll, stained with anti-B220, anti-CD21 and anti-CD23. The 
profiles are representative of results obtained from 6-10 mice 4 month old, and are 
gated on B220 positive cells.
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Figure 24. T cell independent response to PC-Ficoll. (A) lgG3 anti- 
PC reactivity 2 weeks after immunisation with 5pg PC-Ficoll (5 mice per 
group, * p<0.0005 in Student's t-test). Some mice as indicated were 
also treated with either polyclonal or monoclonal IgM starting 24 hours 
after the administration of PC-Ficoll. (B) MZ:FO ratio of splenic B cells 
two weeks after immunisation corresponding to the groups shown in (A). 
*p<0.0003 and **p<0.003 in Student's t-test.
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Autoimmunity in Sp- ipr mice
IgG anti-DNA antibodies in lor and Su- lor mice
Serum IgM deficient mice develop autoantibodies and mild 
glomerunephritis with age (Ehrenstein et al, 2000, and when intercrossed 
into lARUIpr, these mice develop a more severe lupus like disease (Boes et 
al, 1998a). To further determine the role of IgM in autoimmunity, IgM 
deficient mice were intercrossed into Ipr mutant mice in the BL/6 
background, which develops autoimmunity, but not as severe as in the MRL 
background. S\i-lpr, Ipr and litter matched controls were followed for 12 
months. There were no differences in the level of anti-DNA antibodies 
(Figure 25) or proteinuria (++), the only difference was that the S\i-lpr mice 
developed a more severe lymphoproliferation. S\i-lpr mice had a 4-fold 
(2.9x108 cells ± 1.2) and Ipr 2-fold (1.2x10® cells ± 0.6) increase in the size of 
the spleen compared to WT (7x107 cells ± 3), S\i- mice had similar number 
of cells compared to WT. The enlarged lymph nodes of the neck were 
counted. Sp-/prmice had 3 LN weighting 0.25g ±0.10 each, 50% greater 
lymph node enlargement in the neck compared to Ipr mice (2 LN, 0.15g ± 
0.07 each). Mean of 5 mice per group and SD.
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Figure 25. IgG anti-dsDNA antibodies. ELISA of 5 month old Sjx-/pr 
(solid circles) and Ipr (open circles) mice. Blood was taken from the tail 
vein. Dots represent single mouse (15 per group). Means are indicated 
by the horizontal bar. Results given by Units (1 Unit=1.000 OD of a 
MRL/pr)
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Double Negative T cells in Su-/prand lor
Lpr mice are known to a have double negative (DN) T cell population 
that has escaped negative selection. DN T cells bear surface markers, 
which are not characteristic of normal resting T cells, such as B220 (Cohen 
and Eisenberg, 1991). B cells also manifest cell surface abnormalities due 
to Fas mutation, such as early polyclonal B activation, rapid capping of 
immunoglobulin receptors, and high expression of class II MHC molecules 
(Reap et al, 1996).
FACS analyses were performed using B220, IgM and CD3 to see if 
the B, T and DN T splenic cells were different in S\i-lpr compared to Ipr mice. 
S[x-lpr and Ipr mice had less T cells and more B cells at 4 month of age 
when compared to 12 old month mice, S\i-lpr mice had more DN T cells 
characterised by B220/CD3 positive cells at all ages (Figure 26). DN T cells 
in the lymph nodes were increased at 12 month of age (Figure 27).
B cell subsets in Su-/prmice
In order to study the B cell population in the S\i-lpr mice, FACS was 
performed using CD19 instead of B220 because it stains the DN T cells as 
well, IgM, IgD, CD21 and CD23. Cells were gated for lymphocytes and to 
determine the percentage of MZ, FO, T1, T2 and B1 B cells, they were gated 
for B cells only. Splenic and peritoneal cells of 4 and 12 month old S\i-lpr, 
Sp-, Ipr and litter matched controls were used for the cell surface staining 
and analysed by FACS. Figure 28 and 29 show the percentage and SD of
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Figure 26. Splenic double negative T cells, B and T cells.
Histogram showing the percentage of B, T and DN T cells in the 
spleen. Cells were gated for lymphocytes and stained using anti-CD3, 
anti-IgM and anti-B220. Sp-lpr and Ipr mice were 4 and 12 month old 
(5 mice per group ± SD).
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Figure 27. Lymph node double negative T cells, B and T cells
Histogram showing the percentage of B, T and DN T cells in the 
lymph node. Cells were gated for lymphocytes and stained using 
anti-CD3, anti-IgM and anti-B220. Sjx-lpr and Ipr mice were 4 and 12 
month old (5 mice per group ± SD).
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Figure 28. B cell subsets in 4 month old mice. Histogram showing 
the percentage of Follicular, Marginal Zone, Transitional type 1 and 
Transitional Type 2 B cells in the spleen. Cells were gated for 
lymphocytes and stained using anti-CD23, anti-CD21, anti-IgM and 
anti-B220. Sp-, Sp-/pr, Ipr and control mice were 4 month old (5 mice 
per group ± SD).
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Figure 29. B cell subsets 12 month old mice. Histogram showing 
the percentage of Follicular, Marginal Zone, Transitional type 1 and 
Transitional Type 2 B cells in the spleen. Cells were gated for 
lymphocytes and stained using anti-CD23, anti-CD21, anti-IgM and 
anti-B220. Sp-, Sp-/pr, Ipr and control mice were 12 month old (5 
mice per group ± SD).
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T1, T2, MZ and FO B cell subpopulations in the spleen of 4 and 12 month 
old mice.
Marginal zone and B1 B cells are further expanded Su-lor
The ratio of MZ:FO B cells (derived from the absolute number of cells 
in each gate analysed by FACS) was further increased in the S\i-lpr (Figure 
30A), not statistically significant at 4 months, but significant at 12 months 
(Figure 30B), and in the 12-month-old Ipr mice the MZ:FO ratio was 
decreased (Figure 30B). Newly formed B cells or T1 were increased in 4 
month old Ipr (Figure 31 A) and decreased in 12 months Ipr mice (Figure 
31B).
B1 B cells from the peritoneal cavity were also analysed in these 
mice. The Ipr mice had a slight increase in the B1 B cells compared to WT 
and S\i-lpr had it further increased (Figure 32A). In older WT mice the ratio 
of B1/B2 cells was higher, but not in S\x-, S^-/prand Ipr mice (Figure 32B). 
There were no evident differences in the B1 B population in the spleen of 
Sn-/prand Ipr mice.
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Figure 30. Marginal zone B cells in S\i-lpr and Ipr mice. Histogram showing 
MZ:FO B cell ratio derived from FACS analysis. Each bar represents the mean of 
6 mice ± SD. (A) Splenic cells from 4 month old mice. *p<0.0001 and **p<0.003 
in Student's t-test. (B) Splenic cells from 12 month old mice. *p<0.02 and 
**p<0.09 in Student's t-test.
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Figure 31. Transitional type 1 B cells in Sp-/pr and Ipr mice.
Histogram showing T1:FO B cell ratio derived from FACS analysis. Each 
bar represents the mean of 6 mice ± SD. (A) Splenic cells from 4 month 
old mice. *p<0.0001 and **p<0.04 in Student's t-test. (B) Splenic cells 
from 12 month old mice.
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Figure 32. Peritoneal B1 B cells in S|i-/prand Ipr mice. Histogram showing 
CD5+/CD5- B cell ratio derived from FACS analysis. Each bar represents the 
mean of 6 mice ± SD. *p<0.0007 in Student's t-test. (A) Peritoneal cells from 4 
month old mice. (B) Peritoneal cells from 12 month old mice.
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Deficiency of serum IgM leads to an increase in MZ B cells which is 
reversed by polyclonal, but not monoclonal IgM. I propose that this 
difference in the effects of these two preparations of IgM is due to the 
multiple antigen reactivity of polyclonal IgM, acting as an ‘adjuvant’ to deliver 
enhanced antigen driven signals to the BCR. Thus, natural IgM acts to 
regulate B cell selection through, presumably endogenous, antigen mediated 
BCR signalling.
It has become increasingly clear that antigen interaction is critical for 
the development of mature B cells arising out of the much larger pool of 
immature B cells (Allman et al, 1993; Cariappa and Pillai, 2002). It has been 
suggested that MZ B cells are preferentially formed when BCR signalling is 
reduced, such as in CD19 deficient mice (Martin and Kearney, 2000). 
Conversely in the absence of aiolos, which results in enhanced BCR 
signalling, the formation of follicular B cells is favoured (Cariappa et al, 
2001). The pentameric structure of IgM, in contrast to IgG, can potentially 
yield a high avidity for antigen despite a low antigen specific affinity. 
Moreover, one molecule of IgM can activate complement whereas two IgG 
molecules are required (Borsos and Rapp, 1965). Consequently, BCR 
signalling is reduced and MZ B cells are preferentially formed in the absence 
of IgM, despite normal levels of serum IgG. A similar process may apply to 
B1 cells which are also sensitive to antigen drive (Hayakawa et al, 1999),
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since polyclonal IgM rather than monoclonal IgM reversed the expansion of 
this B cell subset.
To test further the effects of serum IgM on B cell selection, a 
transgenic mouse line that secretes a monoclonal heavy chain (Vp1) in 
combination with a variety of light chains was created. In contrast to the 
injection experiments in Sp- mice, serum IgM is constitutively secreted in the 
Vp1s Sp- transgenic mice. The effect of the constitutive secretion of Vp1 on 
the number of MZ B cells was not different from the Sp- alone, consistent 
with the hypothesis that a broad reactivity is needed to influence the mature 
B cell compartment.
B1 B cell numbers only returned to normal after administration of the 
polyclonal IgM preparation. B1 B cell numbers were unchanged in Sp- mice 
expressing the Vp1s transgene suggesting that B1 B cells required the full 
repertoire of polyclonal IgM as well.
The regulation of B1 and MZ B cells is not identical despite the two B 
cell subsets having some shared functional properties. For example, in the 
absence of Baff, a member of the TNF superfamily that specifically regulates 
B lymphocyte proliferation and survival, whereas MZ and follicular B cells are 
reduced, B1 B cell numbers are unaffected (Schiemann et al, 2001). 
Similarly, CD22 has opposing effect on B1 and MZ B cells (O'Keefe et al, 
1996, Sato et al, 1996a, Samardzic et al, 2002). The response to hapten- 
Ficoll also divides these two B cell subsets since it is dependent on marginal 
zone B cells rather than on B1 B cells (Amlot et al, 1985). In Sp- mice MZ B
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cell numbers (but not B1 B cell numbers) further increase with a 
corresponding reduction in follicular cells in response to PC-Ficoll. When 
polyclonal IgM is administered during the immune response to PC-Ficoll, the 
antibody specific titre is diminished. A reduction in MZ B cell numbers 
towards normal levels when polyclonal IgM is administrated is associated 
with this lack of responsiveness. Previous data have suggested that serum 
IgM may inhibit the T-independent immune response (Brodeur and Wortis, 
1980). However, it is unclear whether serum IgM is acting through 
regulating marginal zone B cell numbers or by altering the immunogenicity of 
the T-independent antigen.
There are also changes in the immature B cell pool in the absence of 
serum IgM. Previous observations have demonstrated that reduced BCR 
signaling results in accumulation of immature B cells (Cyster et al, 1996; 
Turner et al, 1997). Immature transitional type 1 (T1) B cells are the targets 
of BCR induced negative selection in peripheral B cell development (Su et 
al, 2002). Serum IgM appears to play a role in this stage of development, 
since serum IgM deficient mice have increased numbers of T1 B cells, thus 
negative selection of the T1 compartment may not be sufficient in the 
absence of serum IgM. Unlike the full reversal of changes in the mature B 
cell compartment following treatment with polyclonal IgM, the increase in T1 
B cells in the spleen is only partially reversed by polyclonal IgM. This may 
be due to the differential sensitivity of mature and immature B cells to 
antigen stimulation and that only a fraction of serum IgM is present following
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the administration of polyclonal IgM. The relative importance of antigen 
stimulation/selection as the B cell develops through the various phases of 
maturation is unclear. Immature B cells are not as dependent on positive 
selection compared to the mature B cell compartment. Thus in Bruton's 
tyrosine kinase (Btk) mutant, the principal defect is at the mature B cell 
stage, immature cells accumulate at the T2 stage with T1 and MZ B cells 
numbers slightly increased (Loder et al, 1999).
One apparent paradox of these observations is the short time (two 
weeks) required to reverse the MZ/follicular ratio coupled with the evidence 
that MZ and FO B cells have a relatively long lifespan (Fulcher and Basten, 
1997, Hao and Rajewsky, 2001). This long lifespan however is shortened 
when immature B cells are differentiating into the mature B cell pool. It is 
known, and confirmed here, that the MZ/FO ratio does change over a two 
week period after encountering T-independent antigens and MZ B cells are 
thought to expand quickly in this scenario (Martin et al, 2001a). Changes in 
B cell subsets could occur with cell proliferation or apoptosis, or by 
interchange between the MZ and FO B cell pools. Immature T1 B cell 
appear to have a lifespan of only a few days. This timeframe probably 
indicates progression to the mature B cell stage. Higher concentrations of 
IgM than is obtained after intraperitoneal injections may result in a further 
reduction in the expanded T1 B cell compartment. Equally, it is possible that 
the changes in the T1 B cells are in response to the MZ/FO ratio and the
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time required for cells to return to normal levels is longer than the two week 
injection period.
The fact that the administration of monoclonal and polyclonal IgM 
have different effects, despite achieving the same serum concentration, 
suggests that the increase in MZ B cells is not due to a feedback mechanism 
that simply senses the IgM concentration. However, polyclonal IgM may 
have an advantage even in this situation if a Fcp receptor binds 
preferentially to the altered confirmation arising out of IgM complexed with 
antigen. This process could involve a putative Fcp receptor, which could act 
to regulate MZ B cell numbers after binding with serum IgM. Thus, without 
serum IgM the negative signal from Fcp would be absent and MZ B cells 
would expand. This Fcp receptor would either have to be expressed 
specifically on B1 and MZ B cells, or that B1 and MZ B cells would be more 
sensitive to the inhibitory signal delivered by IgM than FO cells. An Fcp 
receptor that would specifically down regulate B1 and MZ B cells has not 
been characterised. However, an Fcp receptor has been described although 
this molecule also binds to IgA and is expressed on a comparatively wide 
range of cells (Sakamoto et al, 2001 and Shibuya et al, 2000). Intriguingly, a 
recent report has demonstrated that serum IgM is a ligand for CD19 (de 
Fougerolles et al, 2001), and B1 and MZ B cells are affected by alterations in 
CD 19 expression (Rickert et al, 1995; Sato et al, 1996; Martin and Kearney 
2001b).
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Cell cycling and apoptosis was studied in Sp- and control mice. FO B 
cells from Sp- mice incorporated more BrdU when mice received continuous 
treatment of BrdU in the drinking water for 14 days than the control FO B 
cells, suggesting that FO B cells derived from Sp- mice are cycling faster. 
FO B cells also have a shorter lifespan, since they appear to be dying more 
as assessed by TUNEL. This could explain the reduction in the number of 
follicular B cells in the Sp- mice. BrdU labelling has been used extensively 
to calculate the lifespan of B cells (Rolink et al, 1998) and has shown direct 
correlation between shortened lifespan and reduced size of the mature B cell 
population, even when the influx of immature B cells from the bone marrow 
is normal (Rolink et al, 1999). These results are compatible with the 
hypotheses that follicular B cells need to receive positive signals through the 
BCR to maintain homeostasis and that serum IgM contributes to that signal.
There seems to be no intrinsic defects in the B cell population of Sp- 
mice, calcium mobilisation, proliferation, and development are normal upon 
BCR stimulation in vitro. Calcium flux has been implicated in the selection of 
events that regulate B cell maturation and in antigen receptor triggered 
proliferation. A number of mutations in signaling molecules have been 
identified in deficient mice that compromise B cell development and BCR 
induced calcium release (Healy and Goodnow 1998). Purified immature T2 
B cells differentiate into mature FO B cells in vitro in response to BCR 
crosslinking, but if these cells bear mutations in BCR signalling molecules 
such as Btk, they fail to differentiate into mature B cells and to induce
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calcium flux (Petro et al, 2002 and Genevier et al, 1997). Serum IgM 
deficient T2 cells differentiate into mature B cells in vitro, demonstrating that 
immature B cells from serum IgM deficient mice have the ability to 
differentiate when stimulated.
Marginal zone, B1 and T2 B cells have an activated phenotype 
indicated by how fast these cells incorporate BrdU over time. MZ and B1 B 
cells are thought to be self-renewing (Kantor et al, 1993). Experiments 
where B cell development was blocked by using a inducible RAG-2 
transgene, showed that even when there is no influx of B cells from the bone 
marrow, after 28 weeks MZ and B1 B cells are still found cycling whereas all 
the other subtypes of B cells have disappeared (Hao and Rajewsky, 2001). 
MZ and B1 B cells have a more autoreactive repertoire (Oliver et al, 1999 
and Hayakawa et al, 1999) and may be constantly activated by self-antigens 
without the adjuvant effect of serum IgM. In the absence of serum IgM, 
more self antigens might bind to BCR giving rise to increased numbers of 
autoreactive MZ and B1 B cells in serum IgM deficient mice.
B1 B cells in the peritoneum behave differently from peritoneal B2 and 
splenic B1 B cells. They have diminished ability for intracellular calcium 
mobilisation, aberrant proliferation and increased apoptosis upon BCR 
crosslinking (Morris et al, 1993). They are also enriched with auto-reactive 
cells, that may have escaped negative selection in the bone marrow, but 
once in the periphery these cells could become anergic/hiporesponsive 
(Chumley et al, 2002 and Dal Porto et al, 2004).
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Peritoneal B1 B cells from S|j- and control mice display a very similar 
calcium flux response to BCR crosslinking. B1 cells, however from Sp- mice 
incorporated less BrdU when mice received continuous treatment of BrdU in 
the drinking water for 14 days than the control B1 B cells, suggesting that B1 
B cells derived from Sp- mice are cycling slower. B1 B cells also have a 
longer lifespan, since they appear to be dying less as assessed by TUNEL. 
This could explain the increase in the number of peritoneal B1 B cells in the 
Sp- mice. The mechanisms that govern the survival and homeostasis of MZ 
and peritoneal B1 B cells are probably different. Natural antibodies (IgM) are 
produced by B1 B cells in the peritoneal cavity, these antibodies may be 
very important in controlling the number of B1 B cells down by delivering 
signals through the BCR, B1 B cells are sensitive to BCR crosslinking and 
undergo proliferation and apoptosis (Bikah et al, 1996, Morris et al, 1993 and 
Sen et al, 1999). In the absence of serum IgM B1 B cells proliferate less and 
live longer, suggesting that these cells are probably more 
anergic/hyporesponsive than the B1 B cells in the control mice. Serum IgM 
may be working to “mop up” (auto)antigens and in its absence the 
(auto)antigens are probably binding directly to the BCR making the B1 B 
cells more anergic, cycling and dying less.
When serum IgM KO mice were made Fas deficient, by crossing into 
BL/6 Ipr, they developed more lymphoproliferation, but no change in 
autoimmunity occurred. However, IgM deficient MRL/pr mice develop a 
more severe autoimmune phenotype (Boes et al, 2000). Studies in C1q
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deficient mice showed that the background is very important in the 
development of autoimmunity. In BL/6 C1q '/_ and BL/6 Ipr C1q ''' mice there 
were no evidence of autoimmunity. Mortality was subtlety increased in 
MRL/pr C1q _/' mice, but the degree of autoimmunity was similar to MRL/pr, 
which exhibit a very aggressive early onset of disease (Mitchell et al, 2002).
The more severe lymphoproliferation phenotype in Sp-/pr could be 
due to the lack serum of IgM combined with the Fas mutation, permitting the 
survival of autoreactive cells. This would explain my FACS findings of an 
increase in double negative (DN) T cells and MZ B cells in the spleens of the 
Sp-/pr mice throughout life compared to Ipr mice. These populations then 
decreased with age. The Ipr mice could compensate for the lack of Fas 
mediated apoptosis by different mechanisms of cell death, in which IgM is 
involved. Thus in the absence of circulating IgM, the forming of immune 
complexes and the clearance of cell debris is thought to be reduced (Kin et 
al, 2002). IgM plays a very important role in binding to dying cells and is 
largely responsible and prerequisite for the classical pathway activation 
mediated by C1q. It was also shown that IgM deficient mice have defective 
clearance of apoptotic cells by peritoneal macrophages (Quartier et al, 
2004).
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Natural IgM has a wide range of actions in the immune system. The 
results presented here demonstrate that mice lacking serum IgM have an 
expansion in marginal zone B cells with a corresponding reduction in 
follicular B cells. The increase in marginal zone/follicular B cell ratio (and an 
expansion in peritoneal B1 cells) is fully reversed by administration of 
polyclonal IgM, but not by a monoclonal IgM preparation. Mice engineered 
to have a secreted monoclonal IgM repertoire, with an endogenous 
membrane IgM had a similar marginal zone/follicular ratio and numbers of 
B1 B cells compared to mice lacking serum IgM. The proposal that natural 
IgM, by virtue of its polyreactivity, enhances antigen driven signaling through 
the B cell receptor (BCR) and promotes the formation of B2 and follicular B 
cells is supported by these results. In particular it is not simply the lack of 
serum IgM perse  but the lack of a diverse IgM population.
Splenic follicular B cells have a shortened lifespan whereas peritoneal 
B1 B cells have a longer lifespan in the absence of serum IgM. However 
they are fully able to proliferate and to mobilise calcium responses following 
BCR crosslinking in vitro. These results demonstrate that natural IgM 
regulates the selection of B lymphocyte subsets in the periphery but may be 
working in different ways depending on the location/environment.
Splenic B cells may be continuously activated by self-antigens and 
serum IgM could behave as an adjuvant. Serum IgM complexed with
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soluble antigens would be more immunogenic and therefore deliver a 
stronger signal through the BCR. It is thought that immature B cells require 
a strong BCR signal to differentiate into follicular B cells, therefore in the 
absence of serum IgM the signal delivered through the BCR is weak, and 
MZ B cells are preferentially formed over FO B cells. The reduction in FO B 
cell numbers in the absence of serum IgM is in accordance with the notion 
that mature B cells require a certain level of BCR signal strength and that 
polyclonal IgM is important in increasing antigen immunogenicity. In the 
peritoneum, natural IgM which is mainly produced by B1 B cells may be 
working differently than in the spleen. Others have suggested that 
peritoneal B1 B cells require a strong signal through the BCR. I propose that 
immunogenic auto-antigens are in greater abundance in the peritoneum 
compared to the spleen and these Ags are normally “mopped up” by serum 
IgM reducing their immunogenicity. Thus without serum IgM the increased 
amounts of peritoneal Ags deliver a stronger signal to B1 B cells resulting in 
anergy in this B cell compartment.
The observation that only polyclonal IgM (as opposed to monoclonal 
IgM) is able to downregulate the increased cellular and serological T- 
independent response seen in serum IgM deficient mice supports the notion 
that natural IgM exerts its effects through antigen binding. When serum IgM 
deficient mice were intercrossed with BUQIpr mice no increase in 
autoimmunity was observed. The lack of acceleration of autoimmunity that 
would have been predicted by earlier experiments may be due to differences
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in the genetic background. The fact that B1 and marginal zone B cells were 
further expanded in serum IgM BL/6/pr mice suggests that the link between 
these B cell subsets and autoimmunity is not straightforward.
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FUTURE WORK
These are the main aims of further work:
• to further investigate the mechanisms that underlie the interplay between 
natural IgM and B cell subsets, by looking at the immunoglobulin repertoire 
of immature and mature B cells.
• to study signaling molecules that lead to proliferation (Cyclin D), survival 
(A1) and apoptosis (caspase 9) in the naive and activated B cell subtypes.
• to further characterise the two recently described transitional type 2 (T2) 
subsets, T2 marginal zone precursor (T2-MZP) and T2 follicular precursor 
(T2-FP).
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